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Abstract
An important goal in genomic research is the reconstruction of the complete picture
of temporal interactions among all genes, but this inference problem is not tractable
because of the large number of genes, the small number of experimental observations
for each gene, and the complexity of biological networks. We focus instead on the
B cell receptor (BCR) signaling pathway, which narrows the inference problem and
provides a clinical application, as B cell chronic lymphocytic leukemia (B-CLL) is
believed to be related to BCR response. In this work, we infer population-dependent
gene networks of temporal interaction within the BCR signaling pathway. We de-
velop simple statistical models that capture the temporal behavior of differentially
expressed genes and then estimate the parameters in an Expectation-Maximization
framework, resulting in clusters with a biological interpretation for each subject pop-
ulation. Using the cluster labels to define a small number of modes of interaction
and imposing sparsity constraints to effectively limit the number of genes influencing
each target gene makes the ill-posed problem of network inference tractable. For both
the clustering and the inference of the predictive models, we have statistical results
that show that we successfully capture the temporal structure of and the interactions
between the genes relevant to the BCR. signaling pathway. We have confirmatory
results from a biological standpoint, in which genes that we have identified as playing
key roles in the networks have already been shown in previous work to be relevant to
BCR. stimulation, but we also have results that guide future experiments in the study
of other related genes, in order to further the long term goal of a full understanding
of how and why B-CLL cells behave abnormally.
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Chapter 1
Introduction
One of the fundamental problems in biology is understanding genomic function. While
advances in experimental technology have made it possible to monitor the expression
levels of tens of thousands of genes in parallel, interpretation of data on this scale
requires sophisticated computational methods in order to gain insight into the inner
workings of cells. Ultimately, the goal is a complete picture of the temporal interac-
tions among all genes, but this is an inference problem that is not tractable because
of the large number of genes, the small number of experimental observations for each
gene, and the complexity of biological networks. We focus instead on the network of
temporal interactions in a single signaling pathway which is initiated by stimulation
of the B cell receptor (BCR). Not only does this narrow the inference problem, but
it also has a clinical application, as B cell chronic lymphocytic leukemia (B-CLL) is
believed to be related to BCR response.
B-CLL is the most prevalent leukemia affecting the aging Caucasian population.
Not only is B-CLL currently incurable, but patients suffering from B-CLL often fol-
low divergent clinical courses, with some patients living decades after diagnosis while
others decline and die relatively rapidly, despite chemotherapy [16]. It is thus difficult
to justify an aggressive treatment regimen early in the disease because it is not nec-
essary for the indolent form and is not successful for the aggressive one. In order to
do accurate diagnosis and eventually, targeted treatments, the goal is to understand
as much about the underlying disease process as possible. In terms of recent B-CLL
research, many genomic studies focus on gene-specific changes that are related to
prognosis, as in [13, 17, 19, 24], but a global picture of how and why the differences
in cellular behavior occur does not exist. The key to distinctive B-CLL behavior
appears to relate to the differential ability of the B cell receptor (BCR.) to respond to
stimulus [67]. Therefore, in this work, we infer population-dependent gene networks
of temporal interaction within the BCR signaling pathway.
An important question is how to acquire the data used for model inference. Ideally,
we would measure the levels of expression of proteins and their physical interactions
in the cell, but there is currently no systematic way to directly measure protein
expression levels or biochemical activity of gene products. Expression patterns of the
corresponding mnRNA sequence, however, provide an indirect measure [9], and though
they contain a large amount of noise [39], DNA microarrays measure the transcripts
of tens of thousands of genes simultaneously. Although the time scale of cellular
reactions is on the order of seconds to minutes, acquisition of microarray data at
that rate is not feasible because time series experiments require multiple arrays and
large quantities of biological material. Based upon a pilot study [78], four time points
(60, 90, 210 and 390 minutes) appear to capture the vast majority of the trends in
temporal expression. While it is possible that important events in regulating the
signaling pathway are missed because of restricting analysis to these time points, this
is a necessary practical choice. Another practical choice was made in the number
of subjects to include in the study, so in addition to 6 healthy subjects, 11 patients
were selected on the basis of B-CLL prognosis and response of the cells to BCR.
stimulation. The entire data set, shown in Figure 1-1, is comprised of differential
expression measurements for 54,613 genes, 4 time points, and 17 patients.
The scale of this data set and microarray data in general raises new challenges
and new opportunities. Where it was previously possible to analyze the experimental
results virtually by hand, microarrays provide an overwhelming amount of informa-
tion. Keeping in mind the overall goal of interaction networks, we first identify and
classify genes that are differentially expressed under BCR stimulation. Measuring
stimulated expression with respect to a control distinguishes the genes affected by
Figure 1-1: Log ratios of stimulated to unstimulated expression data. Each row
of the image corresponds to a given gene (N = 54,613). There are four columns,
corresponding to time points, which each include data from the 17 subjects.
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the BCR. paathway from those that are expressed in the cell generally, and BCR stim-
ulation essentially "resets the clock" on the cells, beginning the cascade of reactions in
the BCR. signaling pathway in a synchronized way. Because B-CLL is believed to be
related to genetic differences in BCR. signal competence, having subjects from healthy
and B-CLL populations allows us to combine subject information into cluster label-
ings that are specific to the three subpopulations. Data from different patients and
different time points are generally treated simply as more experimental conditions,
so our approach to clustering temporal expression profiles is unique.
We develop simple statistical models that capture the temporal behavior seen in
the pilot study, and then estimate the parameters in an Expectation-Maximization
framework, resulting in clusters with a biological interpretation. We model genes
that peak at localized time points, i.e. those that have large positive deflections at
tl,t ,t3, or0 t4. Those that are not differentially expressed under BCR stimulation
in that way are classified as the "background" genes. In Figure 1-2, we reorder the
genes for each subject group according to the cluster labels and then, within a cluster,
according to the maximum a posteriori assignment value (i.e. how well the gene fits
the cluster). Visual structure is evident, as high values in yellow or red start at the top
left (first wave, t1) and move down the diagonal to the bottom right (fourth wave,
t 4). Because individual validation experiments are simply not practical for 50,000
genes and would not be generalizable to multiple subjects or different experimental
conditions, we use other measures to determine the success of the clustering, such as
significance, robustness to noise and initialization, and quantification of how well the
data is predicted by the models.
For the inference of temporal interaction networks, there are many times more
samples (genes) than there are observations (time points and subjects), even given
the small subset of genes identified as relevant to BCR. stimulation by the clustering
procedure. Therefore, modeling interactions between every possible pair of genes is
not possible. For example, linear models would require inference of N2 T2 parameters
(where N is the number of genes and T the number of time points) from N x T x P
data points (where P is the number of patients). Because we only have 5 or 6 subjects
Aggressive
Figure 1-2: Log ratios of stimulated to unstimulated expression data, reordered ac-
cording to wave clustering results. Only the 500 genes for each subject group with
the highest a posteriori values for cluster membership are included.
IndolentHealthy
per group, this inference problem is severely ill-posed. Thus we use the cluster labels,
which have a consistent biological interpretation, to define a small number of modes of
interaction between the genes. We also impose sparsity constraints which effectively
limit the number of genes influencing each target gene. Both of these choices are
made in order to make inference tractable, but they are also supported biologically.
In order to represent the dynamic networks of temporal interaction statically, we
show in Figure 1-3 the progression through waves of expression, which is related to
time. Though a single node still represents the expression profile over 4 time points
for that gene, we use the cluster labels of the genes, which correspond to the time
point at which they peak, to show which genes and which interactions dominate at a
given time. From these figures, we make two observations about the networks, which
are confirmed quantitatively in Chapter 5. While sparsity constraints imposed during
inference of models of interaction limited the number of incoming edges to any one
gene, the number of outgoing edges was not constrained. The networks, however,
have a scale-free structure, where a small number of genes have a very large number
of outgoing edges. This is consistent with what has been found in protein interaction
networks [8], where a small number of proteins serve as hubs for very large numbers
of interactions and the others participate in very few interactions. Of the 15 genes
we identify as hubs in the three networks, EGR1, NR4A1, and ZFP36 are already
known to be expressed after BCR stimulation [64, 52]. Those three genes, in addition
to the hubs BTG2, CXXC5, and NR4A3, are transcription factors [51]. It confirms
the expectation that transcription factors would be expected to act as hubs in the
network. The second observation is that "red" edges (those between adjacent waves)
appear to dominate the network, which is consistent with the assumption that genes
are most likely to affect genes in the immediately following wave, even though this
was also not an explicit constraint.
In addition to visualizing the networks, we perform analysis of network structure,
leave-one-out cross validation, and tests of robustness and statistical significance.
These show that the modeling choices we have made are not arbitrary but successfully
capture the relationships between genes. An obvious next step after the networks have
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Figure 1-3: In the leftmost column, wave 2 genes are highlighted in yellow. They are
influenced by wave 1 genes only. These connections are shown in red. In the center
column, wave 3 genes are highlighted, and inputs that are direct (those from wave 2,
which is only one time step removed) are shown in red, while inputs that are from
wave 1 to wave 3 are shown in blue. Finally, in the rightmost column, wave 4 genes
are highlighted, with direct connections from wave 3 genes in red, inputs from wave
2 in blue, and inputs from wave 1 in green.
been inferred and validated mathematically is testing the predictions biologically.
One way to do this is to manipulate the expression levels of a single gene, either by
silencing or overexpression, in an intervention experiment. This is the only way to
distinguish between relationships of causality versus correlation in the local regions of
the network. Because intervention experiments are expensive and time-consuming to
perform, particularly for time series acquisitions, much thought must go into selecting
the target gene. It should peak early in the BCR activation response, so that it will
have downstream effects in the cascade of reactions that can be measured in the time
course of the experiment. It also should be expected to influence many other genes, so
model predictions can be compared to actual measurements. Identification of genes
with these two properties are precisely what wave cluster labeling and the inference
of the predictive models provide. First wave genes are, by definition, those that peak
early in the response. By propagating the effects of a change in a first wave gene to
all the remaining genes in the network via direct and indirect connections, we identify
those genes that appear to play important roles. In Figure 1-4, we show an example of
this type of sensitivity analysis for all the first wave genes in the Aggressive network.
We see qualitatively that a few of the first wave genes have the most prominent
effects on the genes in the network. Over the three subject groups, four genes (FOS,
IER2, JUN, EGR1) identified as potential target genes were found previously to
be expressed by inducing early response genes with BCR, activation [52]. For the
Aggressive network, column i of Figure 1-4 corresponds to the probe set label for
DUSP1, which was selected for the first set of intervention experiments on the basis
of its expression profile and its role in cell cycle regulation [45] and apoptosis [53]. We
examine the consequences of silencing of DUSP1 using small interfering RNA after
BCR activation in a patient with the aggressive form of B-CLL. In the Aggressive
network, DUSPI is directly connected to 37 genes and indirectly connected to an
additional 136. This subnetwork is shown in Figure 1-5, where DUSP1 is white,
second wave genes are red, third wave genes are blue, and fourth wave genes are
green.
Wave 1
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Figure 1-4: For the Aggressive network, the effects of uniformly perturbing each of
the first wave genes on all other genes in the network over time. The leftmost column
corresponds to the wave label.
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Figure 1-5: DUSP1 subnetwork for the aggressive patient group. DUSP1 is white,
second wave genes are red, third wave genes are blue, and fourth wave genes are
green.
To evaluate the predictive ability of the network, we compute scores for each gene
at each time point based on whether the network is able to correctly predict the
direction of change (increase or decrease) from the control experiment to the DUSP1
silencing. For genes in the DUSP1 subnetwork, the model predictions are correct
nearly 70% of the time. Those genes that are unrelated to DUSP1 should, in theory,
have the same expression levels in both the silencing and the control experiments. Any
differences that are seen in the data would be due to noise, which the model should be
unable to predict. The direction of change for these genes is correctly predicted only
approximately 40% of the time. This strengthens the results with respect to those
genes that are related to DUSP1, as the model is uniquely able to predict changes
due to gene silencing. In summary, for both the clustering and the inference of the
predictive models, we have statistical results that show that we capture the temporal
structure of and the interactions between the genes relevant to the BCR signaling
pathway. We have confirmatory results from a biological standpoint, in which genes
that we have identified as playing key roles in the networks have already been shown in
previous work to be relevant to BCR. stimulation, but we also have results that guide
future experiments in the study of other related genes, in order to further the long
term goal of a full understanding of how and why B-CLL cells behave abnormally. In
this chapter, we have motivated the problem of inferring temporal gene interactions,
introduced our approach, and shown a few sample results. We now provide a roadmap
for the remainder of the thesis.
In Chapter 2, we begin with a basic overview of the background necessary to
understand the biological context of the work in this thesis. We briefly describe
how genes are expressed in the cell, and how these expression levels are measured
with microarray technology. We also include a short introduction to B-CLL and its
relationship to the BCR signaling pathway. Finally, we summarize the experimental
procedure used by Vallat et al. [78] to acquire the microarray data set, including the
selection of subjects from both healthy and B-CLL populations and the selection of
time points that capture the behavior of genes differentially expressed under BCR
stimulation.
In Chapter 3, we present a clustering technique that, is able to incorporate prior bi-
ological knowledge and multiple subjects in an Expectation-Maximization framework.
These results are compared to a na'ive approach in terms of statistical significance,
stability, and cluster structure. We show that a small number of representative tem-
poral expression profiles, corresponding to waves of expression that peak at each time
point, are able to successfully capture the underlying structure of the data. Addition-
ally, for our application, clustering serves as a first step in order to make predictive
modeling, as described in Chapter 5, tractable.
We then extend in Chapter 4 the EM formulation from Chapter 3 into a hierarchy
comprised of two layers: an underlying distribution of subjects, which each have an
underlying distribution of genes. This is analogous to a common challenge in microar-
ray data analysis, referred to as biclustering, where the genes and the experimental
conditions (in this case, healthy subjects and B-CLL patients) are simultaneously
clustered in order to identify subsets of genes that behave similarly under a subset of
the conditions. We apply the algorithm to a synthetic data set to show that it can,
in fact, identify clusters embedded in the data, and then to our actual data set to
evaluate the results of simultaneously clustering subjects and genes.
In Chapter 5, we model the interactions between the genes relevant to the BCR
signaling pathway by inferring disease-dependent temporal interaction networks. Be-
cause of the number of subjects that we have available, inferring a network of all
possible interactions is ill-posed. We therefore impose sparsity constraints that are
consistent with biological expectations. We take advantage of the results of the clus-
tering in Chapter 3 in order to infer networks from only those genes that were clustered
as waves of expression, meaning that we reduced the number of genes from more than
50,000 to 500 per subject group. We also use these cluster labels to limit the modes
of interaction possible between genes. Finally, we impose sparsity in terms of the
number of genes that can influence any one output gene. In addition to network
visualization, we provide quantitative analysis of statistical significance, robustness
to noise, and cross validation.
In Chapter 6, we interpret the results from Chapters 3 and 5 from a biological
standpoint and provide a way to use the networks to design future experiments.
We discuss how the structure of the networks corresponds to what is already believed
about networks of protein interaction, despite the fact that these were not constraints
that were imposed. We describe genes that play key roles in the network, and show
experimental results on the DUSP1 silencing experiment which confirms the ability
of our models to predict changes in genes in the DUSP1 subnetwork.
We summarize the work of the thesis in Chapter 7 and briefly discuss the broader
implications of combining machine learning and large-scale biological experiments to
better understand the inner workings of cells and disease processes.
Chapter 2
Biology
2.1 Background
In order to understand the clinical motivation of the work in this thesis, we provide
a brief introduction to the biological context of the data set and the disease. We
describe how microarrays measure gene expression levels and how gene expression
levels relate to cellular function. We also discuss what is known currently about B
cell chronic lymphocytic leukemia (B-CLL), the genomic differences between patient
subgroups, and the relationship to the B cell receptor (BCR.) signaling pathway.
2.1.1 Microarrays
With the advent of DNA microarray technology, the goal of a global understanding
of the inner workings of transcriptional regulatory networks is becoming feasible.
Instead of performing experiments on single genes, it is now possible to measure
expression levels from tens of thousands of genes in parallel. The large increase in
scale, however, raises new challenges and new opportunities. Where it was previously
possible to analyze the experimental results virtually by hand, microarrays provide
an overwhelming amount of information. The question is how to interpret the data
in a meaningful, principled, and useful way.
Treating microarray data as a large collection of traditional experiments that sim-
ply need to be processed in an automated way ignores one of the key advantages.
Global measurements allow us to search out patterns of expression and relationships
between genes. By combining confirmatory results, which simply show that microar-
ray analysis is consistent with previous biological experiments, and new results, we
begin to form a more complete picture of what is occurring in the cell. We dis-
cuss recent work in microarray analysis in the Background sections of Chapters 3, 4,
and 5, but first, a basic understanding of how gene expression works is necessary to
understand how microarrays are used to measure the behavior of the cell.
Central dogma of molecular biology
For a brief, oversimplified view of gene expression, we summarize the central dogma of
molecular biology [18]. DNA provides the genetic code for the cell, and transcription
is part of the method in which the genetic code is used to produce proteins. Proteins
have many important functions in the cell, such as catalyzing chemical reactions,
playing structural or mechanical roles, influencing immune response, and storing and
transporting various ligands. In transcription, a DNA sequence is copied to produce
a sequence of ribonucleotide bases that is referred to as messenger RNA (mRNA)
and carries genetic information to the ribosomes. The ribonucleotides are read by
translational machinery in sequences of triplets (codons) that specify amino acids,
which then make up the protein. Translation of mRNA to protein is followed by
folding, post-translational modification, and targeting.
While DNA microarrays enable measurement of the transcripts (or mRNA se-
quences) of every gene, we cannot measure protein expression levels or biochemical
activity of gene products. These are, generally, what are actually physically inter-
acting with one another and functioning in the cell. A comprehensive picture of the
transcriptional regulatory network would require direct measurements. There is, how-
ever, a sensible link between the expression pattern and function of the gene product
[9]. One reason we are able to infer chemical activity of the gene products is that
they may influence the transcription of other genes. Regulatory proteins are classi-
fied either as activators, which increase the rate of transcription, or repressors, which
decrease it. Also, assuming that cells behave efficiently, transcription of a DNA se-
quence occurs when the corresponding protein is necessary for the cell to function. As
more or less of the protein is needed, the amount of mRNA transcribed is adjusted as
well. Thus, for our purposes, we use mRNA expression levels as an indirect measure
of the behavior of the cell.
Measuring mRNA expression levels
For the data collected for this work, Affymetrix oligonucleotide arrays are used, but
other microarrays work along similar principles. We summarize the acquisition and
processing described by Lockhart et al.[46]. Arrays of thousands of discrete oligonu-
cleotide sequences are synthesized in situ on a slide. Each oligonucleotide relates
to a DNA sequence specific to a particular gene in the human genome. These are
referred to as probes because they serve to probe, or interrogate, the composition of
the population of RNA sequences.
The arrays contain collections of pairs of probes for each of the RNAs to be mon-
itored. Each probe pair consists of a short sequence that is perfectly complementary
(referred to as a perfect match, or PM probe) to a particular subsequence, and a
corresponding sequence that is identical except for a single base difference in a cen-
tral position. The mismatch (MM) probe of each pair serves as an internal control
for hybridization specificity. The analysis of PM/MM pairs allows low-intensity hy-
bridization patterns from rare RNAs to be sensitively and accurately recognized in
the presence of cross-hybridization signals. The target RNA population, which is
comprised of the samples we want to measure, is prepared by incorporating fluores-
cently labeled ribonucleotides in an in vitro transcription reaction and then randomly
fragmenting the RNA to an average size of 50 to 100 bases. After the samples are
hybridized to arrays, fluorescence imaging of the arrays is accomplished with a spe-
cially designed scanning confocal microscope. The resulting images are processed to
compute expression levels based on the amount of fluorescence at each grid cell in the
array.
2.1.2 B-CLL
CLL represents 30% of adult leukemias, with the median survival varying from 2.5 to
14 years depending on the clinical stage. This form of leukemia, despite advances in
treatment, is still incurable. It is characterized by the accumulation of CD5+ mono-
clonal B lymphocytes of mature cytological aspect, but the mechanism of the disease
remains unknown. The mutational status of the VH genes encoding for immunoglob-
ulin (Ig), constitutive of the B cell receptor (see Section 2.1.3), differentiates mutated
(M-CLL) or unmutated CLL (UM-CLL) and is the major prognosis factor of this
leukemia. There are two types of CLL: one with a better outcome, in which mutated
VH genes are expressed, and another with a poor outcome, in which unmutated VH
genes are expressed [20, 54].
The recent technological advances in gene expression analysis by microarrays allow
the description of many molecular differences and similarities between malignant and
healthy cells. Those analyses revealed for all the subgroups of CLL a distinguishable
gene expression pattern for healthy B cells and other lymphoid malignancies, con-
firming that CLL is a unique entity with heterogeneous aspects [33]. Nevertheless,
some genes are differentially expressed with respect to the mutational status that dis-
criminates UM-CLL with a poor outcome [42, 59]. Among them, ZAP-70 seems to
enhance the signaling of the BCR in the more aggressive form of CLL cells [14, 13]. We
hypothesize that downstream abnormality of the BCR signaling pathway conditions
a temporal genetic program specific for aggressive leukemia after BCR stimulation.
The inference of temporal transcriptional networks should provide insight into the
genetic program used by these different categories of cells.
2.1.3 BCR stimulation
The key to distinctive B-CLL behavior likely relates to the differential ability of the
B cell receptor (BCR) to respond to stimulus. Analysis of signal competence in vitro
reveals that unmutated CLL generally continues to respond, whereas mutated CLL is
anergized [67]. Therefore, in order to better understand the B-CLL disease process,
we investigate the B cell receptor and the reactions that comprise the BCR signaling
pathway.
B cells are lymphocytes that play a large role in the humoral immune response.
The human body makes millions of different types of B cells each day, and each type
has a unique receptor protein referred to as the B cell receptor (BCR) on its mem-
brane that will bind to one particular antigen. The BCR on mature B cells consists of
an antigen binding subunit, surface immunoglobulin, and a signaling subunit. Cross-
linking (which we refer to more generally here as stimulation) of the BCR initiates
a tyrosine kinase cascade. During this process, positive and negative feedback mod-
ulates the signal. Activators or repressors, which are mainly transcription factors,
arrive in the nucleus, and the output is the transcriptional program that defines the
cellular behavior. Regulation of the BCR signaling pathway determines whether BCR
engagement leads to activation, anergy or cell death by apoptosis [30, 50, 11], so the
goal is to understand the population-specific core transcriptional programs.
From an experimental standpoint, BCR stimulation provides two important ad-
vantages over most of the other microarray data that is collected. The first is that by
collecting data from stimulated and unstimulated samples simultaneously, we mea-
sure differential expression relative to a control. This should, at least to the extent
possible, distinguish between those genes that are part of the BCR pathway and those
that are expressed in the cell generally. It allows us to narrow our focus, and because
it is the BCR pathway that is expected to be most relevant to B-CLL, that focus will
be on the most important genes.
The second is that most gene expression data is collected at steady state, and
interaction networks that are inferred represent dynamic systems. Steady state be-
havior constrains the dynamic behavior of the network, but does not determine it.
Therefore, building a dynamic model from steady state data is a severely ill-posed
problem [25]. Because cells in the sample are at various stages of the cell cycle, it is
relatively easy to determine which genes are co-expressed, but not which genes have
temporal influence over one another. In contrast, with BCR stimulation, one can
essentially "reset the clock" on the cells, beginning the cascade of reactions in the
BCR signaling pathway in a synchronized way. Then, as data is collected at time
points following stimulation, we observe the patterns of transcription that occur.
2.2 Data collection
For the data set used in nearly all the analysis in this thesis, details of the experimen-
tal procedure are found in Vallat et al. [78]. These are complex and time consuming
experiments, but only a few points of particular importance to this work are presented
here. Peripheral blood was obtained from twelve previously untreated patients diag-
nosed with B-CLL, and six healthy blood donors. B cells were divided in two in
order to control for any effect of ex vivo handling of cells over the time period of the
experiment. One set was used as an unstimulated (US) control, and the other was
stimulated (S) by an antigen. The target cRNA was prepared in accordance with
the Affymetrix protocol and hybridized to the HG-HU133 plus2.0 microarray, which
contains 54,675 probe sets. Microarrays for the 18 subjects were analyzed. Data
were normalized with the invariant set method and the model based expression index
(MBEI) obtained by the pm-mm model using dChip software (dChip) [44].
We calculate differential expression by subtracting the unstimulated expression
level from stimulated expression level. For a clearer visualization, the log ratio of
stimulated to unstimulated is shown in Figure 2-1(a). Each row of the image corre-
sponds to a given gene. There are four columns, corresponding to time points, for
each of the 18 subjects. Neither the genes nor the subjects are in any particular or-
der, and it is difficult to see any kind of structure in the data. Most of the genes are
near zero, which means they are not differentially expressed under BCR stimulation.
For one patient, the expression at the third time point was uniformly higher than
the result of the data. In Figure 2-1(a), this is the bright yellow line marked with
an arrow. This was either a problem with the experiment or the processing, so this
outlier patient is removed from all further analysis. The new data set is displayed in
Figure 2-1(b).
(a) 18 subjects (b) 17 subjects, outlier removed
Figure 2-1: Log ratios of stimulated to unstimulated expression data. Each row of
the image corresponds to a given gene. There are four columns, corresponding to
time points, for each of the 18 subjects. Most of the genes are near zero (light green),
which means they are not differentially expressed under BCR stimulation.
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2.2.1 Patient selection
The role of BCR stimulation in apoptosis versus survival of CLL cells was evaluated
in 23 patients and compared to B cells from 9 healthy donors. For the detailed
microarray analysis, 12 patients were selected on the basis of their mutational status
(see Section 2.1.2) and on their response to BCR stimulation. The goal was to identify
patients who were mutated and unmutated, and also responders and non-responders.
For the analysis in the following four chapters, we use three patient subgroups,
which are assumed to have relatively homogeneous genetic backgrounds. These are
the six healthy subjects, five patients with the aggressive form of B-CLL, and six pa-
tients with the indolent form of B-CLL. The aggressive form generally corresponds to
UM-CLL and the indolent form to M-CLL, but the CLL patients can be subdivided
differently depending on mutational status, prognosis, or gene-specific differences. At
the basal level, without any stimulation, unsupervised clustering fails to discrimi-
nate between patient subgroups, but supervised clustering of Indolent and Aggressive
samples yields a set of genes do separate the two groups [42, 59].
2.2.2 Time point selection
Any gene expression profiling performed over time must first identify the critical
time points required for analysis. The goal is to best capture the trends in the data
while limiting the total number of chips being used. In a pilot study, CLL cells were
isolated and RNA extracted after BCR stimulation at nine time points (baseline,
20, 30, 60, 90, 150, 210, 390 min, and 24 hr). Three patients were selected on the
basis of their functional response to BCR stimulation: one low-responder, one median
responder and one high responder. Using a self-organizing map (SOM) [72], a type of
unsupervised mathematical cluster analysis, eight possible template patterns of gene
expression over time were selected. Based upon this analysis, four time points (60,
90, 210 and 390 minutes) were identified that appeared to capture the vast majority
of these trends. These time points were therefore selected for all subsequent analyses.
Even with only four time points examined and analysis of a relatively small number
of subjects, this experiment required analysis of 144 arrays. While it is possible that
important events in regulating BCR mediated signaling pathways are missed because
of restricting analysis to these time points, it is a necessary practical choice.
Chapter 3
Clustering
In general, clustering provides a method for analyzing the results of microarray ex-
periments, which are a substantial increase in experimental scale as compared to
previously available technology. While tens of thousands of measurements can now
be acquired simultaneously, the data is virtually useless until it can be summarized in
a meaningful way. Gene-based clustering groups together genes that are coexpressed
under various experimental conditions, and such coexpression is believed to indicate
cofunction and coregulation. Results of these clustering algorithms are characterized
by the existence of stable clusters, the shapes of the cluster expression profiles, and
the actual groupings of the genes.
The goal of clustering in this work is to identify and label genes that are differ-
entially expressed under BCR stimulation. From an experimental standpoint, BCR
stimulation of cells from multiple subject groups provides three important advantages
for clustering over much of the gene expression data that is collected. The first is
that we measure differential expression due to BCR stimulation relative to a control.
This should, at least to the extent possible, distinguish those genes affected by the
BCR pathway from those that are expressed in the cell generally. This focuses the
clustering problem to coexpression within the pathway. Second, BCR stimulation
essentially "resets the clock" on the cells, beginning the cascade of reactions in the
BCR signaling pathway in a synchronized way. Therefore, we cluster based on tem-
poral expression profiles instead of steady state response. Finally, because B-CLL is
believed to be related to genetic differences in BCR signal competence (see Section
2.1.3), having subjects from healthy and B-CLL populations allows us to combine
subject information into subpopulation-specific cluster labelings. Data from different
patients and different time points are generally treated simply as more experimental
conditions, so our approach is unique.
Our clustering provides the shape of the cluster profiles, which provides insight
into the structure of BCR response of the cell. We also obtain classifications for all
of the genes, which identifies those that appear to be relevant to BCR (and at what
time point they peak), those that are grouped together, and how the labelings change
depending on the subject group (see Section 6.5). For validation, there is no ground
truth of an exhaustive list of genes that are differentially active, nor which should be
clustered together, and for more than 50,000 genes, these individual experiments are
simply not practical and may not be generalizable to multiple subjects or different
experimental conditions. Thus we have to use other measures to determine the success
of the clustering, such as significance, robustness to noise and initialization, and
quantification of how well the data is predicted by the models.
Additionally, for our application, clustering serves as a first step in order to make
predictive modeling, as described in Chapter 5, tractable. This requires drastically
reducing the number of genes. There is no way to infer all relationships between
50,000 genes at 4 time points with only 17 patients. For linear models, this would
require inference of N2T 2 parameters from N x T x P data points. Even as N is
reduced by excluding genes not relevant to the BCR pathway ("background" genes),
allowing unconstrained interactions between all pairs of genes leads to a problem that
is still under-determined. Therefore, we use the cluster labels, which have a consistent
biological interpretation (as explained in Section 3.2.2) to define a small number of
modes of interaction between the genes. The details of this formulation are presented
in Section 5.2.
3.1 Background
Jiang et al. [39] provide a review of cluster analysis of gene expression data, present-
ing specific challenges pertinent to categories of clustering and several representative
approaches, as well as various methods to assess the quality and reliability of clus-
tering results. We discuss these challenges and how they relate to our application.
The first challenge is that prior knowledge of the structure of the data is usually not
available because cluster analysis is often the first step in mining the data. In this
work, we actually have some insight into the shapes of the cluster profiles because of
what is known about BCR activation, but we also use an approach that requires no
prior knowledge as a basis for comparison of the results. While our method may not
be as useful for a problem where nothing of the structure of the data is known, it
does allow us to obtain more consistent, meaningful clusters than the naive approach.
Second, because of the nature of microarray experiments, gene expression data often
contains a large amount of noise. This is a challenge that we cannot avoid and is
the reason that we present stability and significance results to show that the clusters
that are identified are more than random effects. Third, clusters may overlap one an-
other as genes may play more than one role under different conditions or for different
patients. For example, a set of genes may be involved in apoptosis and another set
in cell division. Some of these genes may be involved in both. We address this with
BCR stimulation, time series acquisitions, and clustering of each subject group inde-
pendently. Instead of having an expression profile which incorporates every possible
condition, we take advantage of the fact that we have labels on subject and stimula-
tion versus control in order to cluster based on disease-specific differential expression
profiles over time. Finally, it is difficult to present the results in a way that makes it
possible to interpret how clusters compare to one another and how genes within the
cluster are related. Graphical representations are suggested, which we have addressed
in several ways: cluster profiles, reordering of the original data, and affinity matrices
showing how often genes are clustered together. We also provide quantitative results
to confirm what is evident visually.
As would be expected, Jiang et al. found no single best algorithm which is the
winner in every aspect. There are also no existing standard validity metrics. In fact,
the performance of different clustering algorithms and different validation approaches
is strongly dependent on both data distribution and application requirements. There-
fore, as we made decisions in the design of the clustering algorithm, we investigated
several approaches. Clustering techniques such as K-means [23], nonnegative matrix
factorization [10], and factor analysis [84] have all been used as first steps in creating
networks of genes. Sturn et al. [70] implement software tools for standard, general
clustering methods such as hierarchical clustering, K-means, self-organizing maps,
principal component analysis, and support vector machines. What none of these
methods provide, often because they are the first steps in data mining, is a way to ef-
fectively incorporate prior knowledge about the expression profiles. However, Pan et
al. [55] use an Expectation-Maximization algorithm to identify differentially expressed
genes for model-based clustering. With a similar EM approach, we are able to design
models according to the previous biological experiments in a flexible framework.
The issue of how to best model time series data, as opposed to observations
under various experimental conditions, is still not addressed. Where time series data
is available, it is often comprised of very few data points, especially compared to
the number of genes. Time series experiments require multiple arrays and large
quantities of biological material, so although the time scale of cellular reactions is
on the order of seconds to minutes, acquisition of microarray data at that rate is
not feasible. Bar-Joseph et al. [2] present a unified model that uses statistical spline
estimation to represent gene time-series expression profiles as continuous curves. This
algorithm successfully models cyclical patterns of dynamic genetic behavior for a
relatively small number of genes, with a relatively high sampling rate (between 7
and 20 minutes between time points). We have only 4 time points, and even when
only two spline segments are used to estimate the curve, this algorithm requires the
estimation of five parameters for each gene in order to align the profiles, in addition
to the spline parameters for the class [26]. This would overfit our data set. Also,
our sampling rate is on the order of hours, and the reactions are triggered by BCR
stimulation, so we do not expect to see the cell-cycle related patterns that appear for
the steady-state acquisitions in yeast. Fleury et al. [27] implement a robust method
for detecting evolutionary trends of expression of mouse retinal genes acquired at
different points over the lifetimes of a population of mice. The temporal structure in
that analysis is relatively simplistic (i.e. monotonic increase in expression), whereas
the temporal structure we expect to encounter in the BCR pathway will be more
complex. Additionally, the time-scale of mouse development is on the order of months,
while the cascade of reaction in the BCR pathway is at a much finer scale. The most
closely-related approach to the one in this work addresses the problem of short time
series data by assigning genes to a pre-defined set of model profiles that capture
the potential distinct patterns that can be expected from the experiment [26]. It
does not address several key issues that we face: combining multiple subjects from
a group, incorporating priors on cluster profile shapes, and the classification of all
genes, instead of only those from statistically significant clusters.
3.2 Modeling expression profiles
We implement model-based clustering in two ways. The first is a general Expectation-
Maximization based clustering algorithm, not designed to take advantage of any of the
expected structure of the data. Wave clustering, however, is influenced by previous
work in biology, which provides a set of shapes for the expression profiles for relevant
genes. Both methods are set up similarly in an EM framework, where the primary
difference is in how the distributions at each time point are modeled. Section A.2 of
Appendix A provides very simple example of how the EM algorithm can be used for
clustering.
Genes are clustered on the basis of their differential expression profiles, which
are computed by subtracting the unstimulated expression levels from the stimulated
expression levels at each of the four time points. The data set X (containing N
genes, P patients, and T time points) is assumed to come from a finite mixture of
probability distributions, with each component corresponding to a different cluster.
The goal is to estimate the cluster memberships and the associated parameters E,
which maximize the likelihood:
M
L(8) = Ep(X; m, O)p(mlO), (3.1)
m=1
6 represents the set of parameters associated with all M clusters, and rm specifies
which parameters in O are used for a particular cluster. The mixture proportions for
each cluster are p(mlO). For a single subject, the conditional probability for a given
gene ,, in a given class is defined as:
T
p(an m, o) = P(Xnt lm, E) (3.2)
t=1
The subscripts on x specify the gene n and the time point t. The product model im-
plies that the time points are independent, which is reasonable given the low sampling
rate. In order to combine data from different subjects within a relatively homogeneous
group, we assume a common labeling of the genes that incorporates the expression
profiles of each of the subjects in that group. This common labeling means that for
every gene, each patient p is considered to be an independent draw from the same
model type, which is reasonable because the disease-related genetic backgrounds of
the subjects are expected to be consistent within a group. Therefore, we compute
the conditional probability for each gene as:
PT
p( Im, 0) =I17 17 pp m ) (3.3)
p=1 t=1
In order to estimate the parameters in O, we use the Expectation-Maximization
algorithm [22], which iterates between Expectation (E) steps and Maximization (M)
steps. In the E step, cluster memberships are conditionally estimated from the data
with the current estimate of O. In the M step, model parameters O are computed so as
to maximize the likelihood of complete data given the estimated cluster memberships.
When the EM algorithm converges, each gene is assigned to the cluster with the
maximum a posteriori probability. For details of the EM derivation, see Appendix
A.
3.2.1 Gaussian clustering
We consider a naive approach to clustering in order to investigate the underlying
structure of the data and to have a basis for comparison with the wave clustering.
We model the clusters as 4D Gaussian distributions, with each cluster having an
associated mean p and variance a2 in each of the dimensions, which here correspond to
time points. To compute the conditional probability assuming Gaussian distributions,
we define:
P(xpt m, 8)= 1 exp -(Zxpt - /mt) 2 ) (3.4)2r2t e2am2
where m specifies which of the parameters in O to use for that particular cluster.
EM iterations
On each iteration k, the current values of all the cluster parameters are Ok. For the
Expectation step, the posterior probability of a cluster, given a gene and the current
cluster parameters, is:
P(mP(n, ek)= )P((3.5)
=-m'=l P(Zm, Ek)P7oP(mlok)
= Wnm (3.6)
These are weights, Wnm, which are used in the Maximization step. Given these weights
at iteration k, we derive a closed form solution for the best estimate of the cluster
parameters for iteration k + 1. The derivation for a, simple example is in Appendix
A. Solving for mtit:
AImt =  EP 1 (3.7)p=1  n=1 nm
This is equivalent to taking a weighted average of the data, based on cluster mem-
berships, to compute the cluster means. In a similar way, the variance for a cluster
is
2 Epl n=1 Wnm(Xnpt - t) (3.)X=mt -N (3.8)
Ep= n=l Wnm
using the value for tmt just computed. Finally, the mixture proportions for each
cluster are:
N
P(mlEk) = N E Wm (3.9)
n=1
Initialization
Because the EM algorithm is only guaranteed to converge to a local maximum, the
result is sensitive to the initialization. As this method is intentionally as general
as possible, we initialize by randomly assigning the genes to M clusters. The initial
cluster parameters are the Maximum Likelihood estimates of the means and variances
given those assignments. The mixture proportions are set to 1
3.2.2 Wave clustering
From a biological standpoint, it has been conjectured that important genes (e.g.
transcription factors) will peak at localized time points [78]. As was explained in
Section 2.2.2, time series experiments were designed to show waves of expression. A
pilot study was done to determine the time points at which data should be collected
in order to capture the maximum amount of information while limiting the total
number of chips. Significant time templates of BCR stimulated effects identified four
time points: 60, 90, 210 and 390 min that appeared to capture the vast majority of
these trends.
We develop simple statistical models that capture such behavior, resulting in clus-
ters with a biological interpretation. Given the templates of the differential expression
profiles from the pilot study, we intend to model genes that peak at localized time
points, i.e. those that have large positive deflections at tl,t 2,t3, or t4. Those that are
not differentially expressed under BCR stimulation in that way are classified as the
"background" genes. The EM formulation is extremely flexible as to incorporating
different types of models (exponential distributions, gamma distributions, etc.) de-
pending on the actual structure of the data. It is also possible to model large negative
deflections as well as large positive deflections, as well as genes that peak at more
than one time point. These particular models were chosen based on the template
shapes in the previously discussed pilot study and work well for this particular data
set, but are not the only ones possible for this clustering method. It is also a simple
matter to add additional clusters or re-adjust the cluster definitions to incorporate
different numbers of time points.
This type of modeling provides a basis for constraining the predictive model in-
ference step (see Chapter 5). The cluster labels first define the subset of genes that
comprise the models. Because only those genes that are differentially expressed under
BCR stimulation are expected to be relevant to the BCR pathway, all background
genes are excluded from further analysis. Selection of the relevant subset is necessary
because inferring predictive models of more than 50,000 genes is not tractable. Addi-
tionally, it is impractical to allow every possible pair of genes to interact in a unique
way, so the cluster labels are used to compute common modes of interaction between
classes of genes.
We define 5 classes of genes. Classes 1 through 4 are composed of the genes that
are predominantly differentially expressed at the corresponding time point and will be
referred to as waves of transcription, e.g. wave 1 genes have high expression at the first
time point and relatively lower expression at the other three time points. Expression is
modeled as a one-sided Laplacian distribution at the time point corresponding to the
genes class label and as a two-sided Laplacian distribution elsewhere. Having heavier
tails than a Gaussian, these distributions better model the considerable variation we
see in genes that are differentially expressed under BCR stimulation.
As in the previous section, we assume the time points are independent, and for
every gene, each subject in a group provides an independent draw from the same gene
model. The probability for a given gene n in a given class is defined by:
PT
p( Im, e) = j p(xnt m, ) (3.10)
p=1 t=l
Depending on the class, the formulation of p(nptn m, -) changes. For waves 1 through
4, the "dominant" time point is defined as being strictly positive, which corresponds
to an increase in gene expression at that time point due to the initial stimulation.
When m (the class label) corresponds to t (the time point), the equations are:
p(xnptm, 6) = Am, exp (-Amnpt) for xpt > 0 (3.11)
p(xnptrm, 8) = 0 for xnt <_ 0 (3.12)
At the other time points, because we expect negative deflections or small positive
deflections, two-sided Laplacians with different positive and negative deflections are
ulsed:
p(xptlm, -) = A exp (--Amt+xnpt) for Znpt > 0 (3.13)
p(xnptlm, ) = - exp (At-xnt) for zpt < 0 (3.14)
The parameters for the distributions at the non-dominant time points are Amt+, which
are unique to each model and are expected to be larger (thus modeling smaller de-
fiections) than Am,, and At-. The parameters for the negative deflections, At-, are
shared across the four wave models. Because these parameters are shared, the nega-
tive deflections will be equally likely under each of the models and will not have an
impact on the assignment of a gene to a particular class. Given the expression profile
templates in the pilot study described previously and the fact that we select genes
that are associated with BCR stimulation on the basis of increased response, we focus
on positive deflections. This is a modeling choice, which for other applications could
be easily changed.
The final class is the background, which is composed of genes that are not differ-
entially activated with BCR stimulation and are modeled by a zero-mean Gaussian
distribution at each of the four time points.
P(znpt m, 8) - 1 -X___ (3.15)
We use the EM Algorithm again to estimate the parameters of the distributions and
the class memberships of each gene.
EM iterations
In exactly the same way as the Gaussian clustering method, the Expectation step is:
P( Ijm, ()k)P(mek)P(m n k ) =(m ) (3.16)
= nm (3.17)
In the Maximization step, given these weights that were computed, we again have
closed form solutions for the parameter values. Beginning with the background class,
the variance at each time point is:
at = Z Z WnmXipt (3.18)
p=1 E n= 1 Wnm
The remainder of the parameters are for the wave classes. For Am., the peak time
point, when m = t:
Am* = (3.19)
p=1 ZnExnp>O Wnm
Instead of summing over all N genes, only those with xrPt > 0 are included. Currently,
we impose a hard constraint on Am,, which guarantees large positive deflections at
the cluster's peak time point. For the non-dominant time points, when m $ t:
Amt+ =1 EnExnpt>O WnmXnpt (3.20)Xmt+= p (3.20)
p=1 nlEXnl;t>O nm
For the shared parameter At-:
At M (3.21)
Zrm=l p=1l ZnEXnpt<O Wnm
The summations are over the four wave classes (from m = 1 to m = M - 1) and the
summation over the genes is for all xnpt < 0. The formula for the mixture proportions
is also the same as it was previously:
N
n=1
Because the mixture proportion of the background class is expected to be much larger
than that of the other classes, one could add a prior here. However, because of the
initialization (described in the following section), and the constraint on Am., we have
found that p(mlek) converges quickly without a prior, as is shown in Figure 3-1.
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Figure 3-1: Mixture proportion for the background class as the EM algorithm con-
verges
Initialization
Instead of randomly assigning initial class labels, we initialize the parameters based
on the types of genes we expect to see in each class. We compute the ML-estimates
of each Amt+ from all the genes at that particular time point.
NPAmt+ NP(3.23)
Z'n=1 Is(npt.
The Am. are proportionally smaller (about 0.01Amt+) because smaller values of A allow
for larger deflections, which will correspond to genes that peak at that time point.
At- is set initially equal to the Am, at that time point, in order to allow for large
negative deflections at the non-dominant time points. In Figure 3-2, we show the
probability distribution functions for this initialization for the healthy subjects. The
flatter the distribution (smaller A), the more likely large deflections. For the initial
mixture proportions:
p(mlOe) = e for m < M (3.24)
p(mIO) = 1 - (M - 1) x E for m = M, (3.25)
where e is the approximate fraction of genes in each wave class.
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Figure 3-2: Probability distribution functions for the background class and four wave
classes at each of the four time points, given the parameter initialization (healthy
subjects)
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Figure 3-3: Number of genes selected as a function of MAP value threshold
Threshold selection
After the EM algorithm converges, each gene is assigned to the class according to its
maximum a posterior (MAP) probability under the model. We choose to threshold
based on this MAP value in order to include the top 500 genes from each subject
group. There are several reasons for this. In order to compare results across groups,
we work with a consistent number of genes per group. It also allows us to further
pare down the number of genes for visualization and predictive model inference in a
principled way. In Figure 3-3, we see that by varying the threshold, the number of
genes that would be included changes. As it becomes more practical to work with a
larger number of genes (or if one were working with a different data set altogether),
the threshold can be adjusted.
3.3 Model comparison
We first evaluate the quality of the clustering result quantitatively. In this section,
we compare the number of parameters for the models, cluster labelings, shapes of the
cluster profiles, likelihood scores, statistical significance, and stability. The biological
^
interpretation of the results is presented in Chapter 6.
3.3.1 Numbers of parameters
For the Gaussian clustering, there are 2 x T parameters associated with each of the M
clusters: a mean and variance corresponding to each time point. In Figure 3-4(a), we
vary the number of clusters, M, from 1 to 20, and record the log likelihood score of the
clustering. The scores of the three subject groups are separated consistently. While
this would appear to show a difference between the groups, it is an effect of using
the same set of patients over the trials. A random re-grouping of the subjects, shown
Figure 3-4(b) yields the same type of separation. Also, the score for the Aggressive
group is higher than that of the other two groups, but this is because it has only
5 patients, as compared to 6 in each of the other two groups. After we normalize
over the number of patients, time points, and genes, it actually has the lowest score
in Figure 3-4(c). The only conclusion to be drawn from these figures is the trend
we see in how the score changes with increasing M. It converges quickly, and at
approximately M = 4 or M = 5, there is little improvement in the score. All the
further analysis of the Gaussian clustering will use M = 5, in which 40 parameters
are estimated.
By definition, the wave clustering has T parameters associated with the back-
ground class, as there is a. zero mean Gaussian distribution with an associated vari-
ance, at, at each time point. For each wave class, there is one corresponding Am.,
which represents the distribution of the positive values for the dominant time point,
and T - 1 Amt+ parameters, which represent the non-dominant time points. Addi-
tionally, there is a shared parameter across the wave classes for the negative values
at each time point, At_. There are thus T x (M + 1) parameters, or specifically 24
in this case. The probability distribution functions for the parameters after EM has
converged are shown in Figure 3-5. Despite the fact that M = 5 for both types of
clustering, 16 more parameters are estimated in the Gaussian clustering.
(a) Aggregate score
ELD
A
V
-5.5
-6.5
-7
-7.5
4 a 1 1 5 1
4 a 8 10 12 14 16 18 20
Number of clusters
(b) Random subject groups
(c) Normalized score
Figure 3-4: Log-likelihood scores as a function of the number of clusters for the
Gaussian clustering
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Figure 3-5: Probability distribution functions for the background class and four wave
classes at each of the four time points, after the EM algorithm converges (healthy
subjects)
3.3.2 Cluster labels
The purpose of the clustering was to identify the subset of genes that are differentially
active and have common structure out of the original data, which is shown in Figure
3-6. In this section, we compare the structure of the clusters resulting from both the
Gaussian clustering and the wave clustering.
For the wave clustering, we threshold the MAP values of cluster assignments to
select 500 genes for each subject group, as was explained in Section 3.2.2. We reorder
the genes for each subject group according to the cluster labels and then, within a
cluster, according to the MAP values. There is visual structure evident in the data
in Figure 3-7, as high values in yellow or red start at the top left (first wave, t - 1)
and move down the diagonal to the bottom right (fourth wave, t4 ').
Because the Gaussian clusters have no a priori interpretation, an analogous vi-
sualization would include all 50,000 genes. Because such a large percentage of these
genes are background, and in order to compare the results in a consistent way, we use
the same 500 genes selected by the wave clustering, but instead reorder them by the
Gaussian cluster labels and MAP values. This is shown in Figure "3-8, where for each
of the groups, the 500 relevant genes are separated into either two or three clusters. It
does not appear that the clusters correspond in any way to the patterns of expression
we see for the wave clustering.
We show quantitatively in Table 3.1 how the cluster labels differ. We compare the
cluster memberships for the Aggressive group given results from the wave clustering
and from a random trial of Gaussian clustering. Background genes comprise three
entire Gaussian clusters and a large proportion of the other two remaining clusters.
Nearly all wave 1 and wave 2 genes were in cluster 1, but the other two waves were
split between clusters 1 and 2. This result is similar to what was seen for other trials
and other subject groups. Additionally, larger values of M subdivided the background
class further, but did not change the classification of non-background genes.
Figure 3-6: Log ratios of stimulated to unstimulated expression data. Each row of
the image corresponds to a given gene. There are four columns, corresponding to
time points, for each of the 17 subjects.
54
Aggressive
Figure 3-7: Log ratios of stimulated to unstimulated expression data, reordered ac-
cording to wave clustering results. Only the 500 genes with the highest a posteriori
values for cluster membership are included.
IndolentHealthy
Aggressive
Figure 3-8: Log ratios of stimulated to unstimulated expression data, reordered ac-
cording to Gaussian clustering results. Only the 500 genes selected by the wave
clustering are shown.
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Table 3.1: Comparison of labels for Gaussian clusters and wave clusters
Background
Wave 1
Wave 2
Wave 3
Wave 4
Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5
1056 2374 3742 13876 33065
16 1 0 0 0
37 3 0 0 0
194 48 0 0 0
106 95 0 0 0
3.3.3 Cluster profiles
For the Gaussian clustering, we show in Figure 3-9 several sample results for each
subject group because of the effects of the random initialization. The mixture pro-
portion for each of the clusters is included in the legend. There are generally two to
three clusters that are nearly zero-mean that comprise the vast majority of the genes,
which would correspond largely to the background class in the wave clustering (see
Table 3.1). The remaining clusters are a smaller proportion of the genes but have
larger differential expression. The cluster means for the non-background classes are
relatively unstable and though the majority of the background genes are grouped with
one another, many are included in the other clusters as well, which is why the means
have relatively small magnitude. Standard deviation error bars are not included in
the figure because they are, at each time point, several times as large as the mean.
We show this with the bar plots in Figure 3-11(a), where we compute a ratio of the
standard deviation at each time point to the maximum absolute value of each cluster
mean. We use the maximum value instead of the actual mean value at, each time
point because it better represents the scale of the cluster mean. Fobr example, at an
off-peak time point (usually tl) the mean value may be very small and that makes
the standard deviation ratio very large, even though what is most, important is the
ratio at the cluster's peak time point.
We compute the cluster means and standard deviations for wave clustering as
- 0.026 - 0.23
400 - 0, 045 400 - 0.024
- 0.23 -0.66
20 0082 - 0.044200 - 0 .64 200 - 0L047
o 0
1 2 3 4 1 2 3 4
Time Tme
I
2
(a) Healthy
80 - 05712 800 - 025
_0 - 14 8 - 0.02
.- I - o08 I 400-
-- 0.025 - 0.01200 200
-20M 200
1 2 3 4 1 2 3 4
Time Time
(b) AggressiveS - 0,081 600. - 0.12
400 - 008 - 0.2
- 0,028 - 0.013
200 2M
2 10
-100 . 2M0
1 2 3 4 1 2 3 4
Time Time
(b) Aggressive
2 0 1 -5 0
1 2 3 4 1 2 3 4
Time Time
.2
2
2
Time Time
(c) Indolent
Figure 3-9: Cluster means for four random trials of Gaussian clustering (M=5) for
each subject group. Because the results greatly depend on the initialization, cluster
means are not consistent across trials.
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Figure 3-10: For wave clustering, the cluster means for each of the three subject
groups.
well, showing the four non-background classes in Figure 3-10. The means have larger
magnitude as compared to the Gaussian clustering because fewer of the background
genes are included in these clusters. The wave clusters have consistent shapes for each
subject group, with comparatively smaller intra-cluster variance relative to the means
(see Figure 3-11(b)). For the background class, there is a very high ratio because the
means are essentially zero, and all genes that do not fit the wave models are assigned to
the background class. This includes genes that are not highly differentially expressed
at all and those genes that are not highly differentially expressed consistently across
subjects within a group. Forcing these two types of genes into a single cluster means
that this type of clustering does not effectively model these genes. However, because
the purpose of the background class is only to identify genes to be excluded from
further processing, it is not essential for them to well-represented by the cluster
parameters.
The standard deviation ratio results in Figure 3-11 are important because when
there is high variance relative to the mean, misclassification of genes is more likely. To
quantify the confidence in the cluster assignment, we show in Figure 3-12 histograms
of the MAP assignment values for the 500 selected genes under both clustering meth-
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Figure 3-11: Ratio of standard deviation for each cluster at each time point to the
maximum of the cluster mean
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Table 3.2: Log-likelihood scores
Wave clustering Gaussian clustering
Healthy -7.56e + 06 -6.59e + 06
Aggressive -6.83e + 06 -5.89e + 06
Indolent -7.40e + 06 -6.40e + 06
ods. The means are 0.9990, 0.9994, and 0.9993 for the wave clustering for each group,
and 0.9822, 0.9864, and 0.9733 for the Gaussian clustering. While these are all high
values, there is lower a posteriori probability for the Gaussian assignments.
3.3.4 Score comparisons
An obvious method to compare the performance of two EM-based clustering algo-
rithms is to compute the log likelihood scores, as that is the score that the iterative
EM algorithm is maximizing. This is the log of the likelihood of the data as a function
of the parameters of the model. In Table 3.2, for every subject group, the score for
the Gaussian clustering is superior to that of the wave clustering.
This result would imply that the Gaussian clustering does a better job modeling
the structure of the data. Though there are 16 more parameters estimated in the
Gaussian clustering for M = 5, this is not simply a case of a better fit because of
more parameters. From Figure 3-4(a), we see that even for M == 3, the scores are
still better when the number of parameters is the same for both clustering methods.
There are a few reasons for the difference in score. First, as explained in Section
3.3.3, background genes are not well modeled by the wave clustering. Because these
genes make up an extremely high percentage of the total and the score is an aggre-
gate value, it is greatly influenced by these genes. They could be better modeled if
we were to subdivide the background class further, which is exactly what happens
automatically in the Gaussian clustering, but that only adds unnecessary parameters
to the modeling. A more important consideration is that we only allow for four types
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Figure 3-12: MAP values for the 500 genes identified by the wave clustering
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of non-background genes, when there obviously would be some genes that would be
better represented by models that have high differential expression at multiple time
points. This is a limitation, but we make choices based on the pilot study to use the
smallest number of models (which is helpful for the predictive modeling) that capture
most of the structure in the data.
3.3.5 Significance results
One method for estimating the statistical significance of a clustering result is the
use of permutation statistics [56, 26]. Permutation methods for computing statistical
significance exploit the exchangeability in order to generate valid samples from the
null hypothesis. In our particular case, the null hypothesis states that the statistical
properties of our sample do not vary with time. Consequently, to generate samples
from this hypothesis, for each trial, we randomly permute the time points for each gene
independently (but consistently within a subject group). The clustering algorithm
is run on each of these permuted data sets and the log-likelihood score is stored.
The estimated p-value is defined as the fraction of trials from the null hypothesis
that result in a higher log-likelihood score than the original data. Comparisons of
log-likelihood scores here are within the same model distributions, so we avoid the
ambiguity that was an issue in 3.3.4 when we compared across different model shape
distributions. In Figures 3-13 and 3-14, we show histograms of the likelihood scores
for 100 trials. The distribution of the likelihood scores for the wave clustering over
the Indolent group appears to be bimodal, but the reason for this is still a.n open
question.
These distributions of permuted scores are compared to the scores for the actual
data in Tables 3.3 and 3.4. For wave clustering, the actual data has a better score in
each of the 100 trials, so our estimated p value is < 0.01 for each subject group. For
the Gaussian clustering, the actual data has a better score in each of the 100 trials
as well. Though the statistical significance results of the two clustering methods are
indistinguishable in terms of p-values, the distributions of the permuted scores are
closer to the actual scores. We quantify this difference by computing an upper bound
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Figure 3-13: Histograms of log-likelihood scores for permuted data (Wave clustering)
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Table 3.3: Significance for Wave clustering
Log-likelihood score p-value Chebyshev value
Healthy -7.56e + 06 < 0.01 < 3e -- 05
Aggressive -6.83e + 06 < 0.01 < 3e -- 06
Indolent -7.40e + 06 < 0.01 < le -- 04
Table 3.4: Significance for Gaussian clustering
Log-likelihood score p-value Chebyshev value
Healthy -6.59e + 06 < 0.01 < 0.09
Aggressive -5.89e + 06 < 0.01 < 0.03
Indolent -6.40e + 06 < 0.01 < 0.06
on the probability of a value higher than the actual score coming from the distribution
of permuted scores, assuming we can characterize the distribution with a mean and
variance. We use a one-tailed variant of the Chebyshev inequality, with k > 0, which
is:
1
Pr((X - /z) > ko) < 1 (3.26)1 + V
These values are included Tables 3.3 and 3.4. We see a difference of two to four orders
of magnitude, depending on the group, in favor of the wave clustering. Because the
Chebyshev value is only an upper bound, it provides the worst case for the probability
of the permuted distribution producing a higher value than the actual score, so it is
not equivalent to actually running the corresponding number of permuted trials.
We interpret the statistical significance of both methods of clustering as the algo-
rithms having captured the differences in the parameters of the distributions of the
data at each time point. While this does not imply temporal coherence, it does show
that the structure of the data is such that the order of the time-series is important.
3.3.6 Stability
As we recognize that there is inconsistency even within relatively homogeneous sub-
ject groups and that microarray data is noisy, it is particularly that important the
clustering algorithms be robust. Beginning with the Gaussian clustering, we inves-
tigate the effects of random initialization. Figure 3-15 is an image of how often two
genes are clustered together over 25 trials of Gaussian clustering. Because of the dif-
ficulty in displaying a 50, 000 x 50, 000 matrix, only the 500 genes per subject group,
selected by the wave clustering and re-ordered according to a random Gaussian trial
(as in Figure 3-8), are shown in the left column. There is clear structure, showing
that the 500 genes are subdivided into two or three fairly consistent groups. We see
in the right column of Figure 3-15, however, as we reorder according to the wave
clustering results, that these clusters do not correspond to the wave clusters at all.
Because the initialization is set for the wave clustering, there is no dependence on a
random initialization.
In addition to the random initialization, we know that microarray data is noisy.
We model this noise by adding zero-mean Gaussian noise (a = 40, about an order of
magnitude smaller than the positive deflections of wave 1 genes) to the input data, in
order to test the robustness of the clustering. We show in the left column of Figure
3-16 an image of how often genes are clustered together, reordered according to the
Gaussian cluster labels in the same way as the left column of Figure 3-15. The same
clusters appear, although they are now somewhat less stable. In the right column, as
they are ordered by wave type, there is once again little structure.
We compare the stability of the Gaussian clusters to the results of having per-
turbed the input data (a = 40) for the wave clustering, shown in Figure 3-17. The
genes that have the same label are generally clustered together in most of the trials.
This comparison is shown quantitatively in Figure 3-18, where we compute the mean
fraction of trials a gene is clustered with the genes in the same wave (excluding it-
self) and the mean fraction of trials a gene is clustered with other genes in the three
remaining waves. For the Gaussian clustering, with the exception of wave 1 genes for
(a) Healthy (Gaussian ordering)
(c) Aggressive (Gaussian ordering)
(b) Healthy (Wave ordering)
(d) Aggressive (Wave ordering)
(e) Indolent (Gaussian ordering) (f) Indolent (Wave ordering)
Figure 3-15: Cluster stability for random initializations for Gaussian clustering
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Figure 3-16: Cluster stability for perturbed input data for Gaussian clustering
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Figure 3-17: Cluster stability for perturbed input data for wave clustering
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Figure 3-18: Blue is the mean fraction of trials a gene is clustered with other genes
in the same wave, red is the mean fraction that a gene is clustered with other genes
in the three remaining waves.
the healthy subjects, these values are nearly equal, which means there is no differen-
tiation between waves of genes. The wave clustering, however, consistently clusters
genes in the same waves together and in different waves separately.
3.4 Summary
We have shown with our clustering that we can represent the temporal structure
of the BCR stimulation response with few models which correspond to waves of
expression that peak at each of the four time points. We obtained classifications for
all of the genes, identifying those that appear to be relevant to BCR and at what
time point they peak. The effect of subject group on the labelings is discussed in
I
Section 6.5. Compared to the Gaussian clustering, the wave clusters have consistent
shapes for each subject group, with smaller intra-cluster variance relative to the
means. Genes are also consistently clustered in the same waves together and in
different waves separately, despite perturbations of the input data with noise. Both
clustering procedures show that there is statistically significant temporal structure
that can be extracted from the data. We have shown for our application that the
wave clustering produces stable, consistent and meaningful models of the differential
expression profiles of genes related to BCR stimulation. In addition to the results
presented in this chapter, wave clustering serves as a first step in order to make
predictive modeling, as described in Chapter 5, tractable.
Chapter 4
Hierarchical Clustering
In much of the genetic research in B-CLL, the focus has been on classifying patients
into subgroups to more effectively plan a course of treatment. These approaches gen-
erally consist of identifying a single gene or small number of genes that are useful in
discriminating between the aggressive and indolent forms of the disease and do not
explain why or how those genes are behaving differently and what effect they have oil
the resulting regulatory network. Without a more global picture of the differences in
cellular behavior, designing targeted treatments is virtually impossible. On the other
hand, combining information from all genes for a patient clustering approach is a
challenge because there are thousands more features (genes) than samples (patients).
These difficulties are well summarized by Xing and Karp [82]: samples may be clus-
tered accurately in many different ways, most of which are not necessarily biologically
meaningful; a large number of features are not relevant; and generalization is difficult
because clustering on the large feature space tends to overfit the data.
This is exactly the case for our B-CLL data set as we have measurements from
more than 50,000 genes but only 17 subjects. We use BCR stimulation to attempt
to identify those genes that are relevant to the BCR signaling pathway, but this
may not necessarily be the same subset of genes that will accurately discriminate
between patient populations. Some differentially expressed genes will behave similarly
across all patients, and some, which are useful for patient classification, will behave
differently. Because we ultimately intend to infer models of temporal interaction that
show where similarities and differences occur, both of these types of genes should be
included in further analysis.
In this chapter, we formulate an integrated approach for combining clustering of
patients with classification of genes, such as the method in Chapter 3. The result will
provide a breakdown of relatively homogeneous subject groups, which is necessary
for the implicit assumption of consistent expression behavior in predictive modeling
(see Chapter 5).
4.1 Background
The simultaneous clustering of both genes and samples is a common challenge in
bioinformatics. Current thinking in molecular biology holds that only a small subset
of genes participate in any cellular process of interest, and that a cellular process
takes place only in a subset of samples. Therefore, biclustering applies to virtually
any problem where data from any different experimental conditions (disease category,
immune response, temperature, time, etc.) has been acquired. The first part of this
section will address current work in biclustering, but because our samples are not
simply a value for each gene for each patient, but an entire temporal expression profile,
we can take advantage of the extra, dimension of data in an interesting way. In the
second part of this section, we discuss related problems in other fields which utilize
hierarchical EM algorithms and actually better address the goal for our application.
4.1.1 Biclustering
Cheng and Church [15] were the first to apply biclustering to gene expression data,
simultaneously clustering both genes and conditions in order to identify groups of
genes that are co-regulated under a subset of conditions. Their algorithm identifies
biclusters with low mean squared residue, defined as the variance of the set of all
elements plus the mean row variance plus the mean column variance. Because this
problem is NP-hard, an efficient node-deletion algorithm is presented. Similar meth-
ods have been proposed more recently which extend the original algorithm by using
a probabilistic algorithm to discover sets of possibly overlapping biclusters [83] or by
iteratively refining the biclusters by adding more genes and/or conditions [87].
Coupled Two-Way Clustering (CWTC) [31] looks for pairs of a relatively small
subset of features (either genes or samples) and of objects (samples or genes), such
that when the objects are represented using only those features, clustering yields
stable and significant partitions. Finding such pairs of subsets is also computation-
ally hard; the CTWC method produces such pairs in an iterative process. Other
algorithms use bipartite graph representation [73], hyperplanes in the data [29], pre-
processing combined with linear algebra [74], probabilistic models[66], feature filtering
[82], and block mixture modeling [32]. For a more complete summary, Madeira and
Oliveira [47] survey recent work in biclustering. Time series data is also relatively
rare, and when it is available, it is often treated as simply additional experimental
conditions. This is addressed by Zhang et al. [86], where the typical mean residue
score measure is used, but deletion from a bicluster is only allowed at the starting
and ending points of the time interval.
For all of these techniques, as for clustering in general, evaluating the quality and
validating the results is difficult. One common approach is to embed synthetic biclus-
ters in the data and then retrieve them with the clustering algorithm. Additionally,
there are data sets available for simple model organisms, such as yeast, where much
of the transcriptional regulatory network is well-understood. Finally, data sets from
diseases, where the patient subgroups and many of the key genes are known, are also
available. There is, however, no other immune response time series data set similar
to the BCR acquisition we analyze here.
4.1.2 Hierarchical EM
Our application is dissimilar to other biclustering approaches because we are not
simply looking for genes that make up significant biclusters. We do not want to
solely identify those genes that discriminate patient populations. As in Chapter 3,
the clustering is not only intended to be a result in and of itself, but also as a first step
in the predictive modeling discussed in Chapter 5, so a complete classification of genes
for each patient cluster is necessary. Also, because we are trying to model all subjects,
we do not want to ignore those that do not have perfectly consistent behavior. In
other words, instead of isolating subsets of the data that form biclusters, we intend to
label the entire matrix of data. The problem is therefore better described as clustering
a data set that is comprised of patients that can be divided into subgroups, which in
turn are comprised of genes that can be divided into subgroups as well. This is closely
related to probabilistic Latent Semantic Analysis [37], where a collection of documents
(or subjects) contains topics (or waves) which are comprised of terms (or genes),
though there are important differences. We assign subjects to subpopulations based
on the wave to which each gene, which would correspond to classifying a document
based not on which topics are present, but on which terms belong to which topics
(i.e. how their meanings change depending on the context). Additionally, terms
are often repeated in documents exactly, while microarray data is noisy and would
require considerable pre-processing to attempt eliminate what would be equivalent
to inconsistent spelling. Despite differences in the details, the formulation is similar.
It is also analogous to work done in image classification [12, 76], word segmentation
[57], and learning object maps for robot environments [1], in which EM is used to
learn parameters at multiple layers of a hierarchy.
4.2 Patient clustering
We begin by temporarily ignoring the hierarchy and simply clustering the patients.
We treat each patient as a sample and each gene as a feature, which is a natural
alternative to the clustering approach presented in Chapter 3, where we treated each
gene as a sample and each patient as a feature. To model this, we assume that subjects
come from a finite mixture of probability distributions. The likelihood function, where
c represents the hidden patient class label, is defined as:
C
L(O) = Ep(X; c, O)p(cle) (4.1)
c=1
We use EM (see Chapter 3 and Appendix A) to cluster by combining the data for
each patient into an NT x 1 feature vector x, where N is the number of genes
and T is the number of time points in the expression profile. Each cluster has N x T
independent Gaussian distributions, each with a mean 'c and variance 6 . Ek includes
all parameters of all the clusters at iteration k. Because we believe there are three
main subgroups (Healthy, Aggressive, and Indolent), we set C = 3. In the Expectation
step, we compute the P x C matrix of weights, where each entry is defined as:
P(x Jc, k)P(c ) (4.2)P(cI,, Ok) = ( . )e ·c=1 P(p(Ic, ek)P(ClEk)
=wpc (4.3)
where, for a mixture of Gaussians, P(x• c, Ok) is:
NT
N- Il l -(xT - X ic_ )2  (4.4)P( lc, k)= exp 2o ic
In the Maximization step, we solve for 'c:
c pP1 pc P (4.5)Ep=1 Wpc
This is equivalent to taking a weighted average of the data to compute the cluster
mean. Similarly, the variance for a cluster is (using the value for [c just computed):
62 pP1 pc - tc)2 (4.6)
p-p=1 WP
c
Finally, the mixture proportion for a given class, P(clOk), is computed as:
P(clek) = PC (4.7)
n=1
In clustering samples (patients), many of the genes are irrelevant, i.e. they do not
contribute to a meaningful, consistent clustering [82]. To reduce the dimensionality
of the feature space, we use the gene classification results in Section 6.5 to obtain
a subset of genes believed to be relevant to the BCR signaling pathway. While
not all of these are necessarily useful to differentiate across subject groups, it does
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Figure 4-1: Affinity matrix for the 17 subjects, showing how often each subject pair
was clustered together over the 1000 trials
provide a more reasonable size set of genes with which to cluster. There are a total
of 1028 genes (see Figure 6-18) as compared to 54,613. Also, EM only guarantees
convergence to a local maximum, so the final clusters depend on the initialization.
Over the k = 1000 trials, we randomly assign each of the subjects to a cluster, compute
the resulting means and variances, and then iterate between the Expectation and
Maximization steps described above until the cluster memberships are stable. Given
the cluster assignments for each trial, we compute an affinity matrix in which each
entry represents the number of times any pair of subjects were clustered together. In
Figure 4-1, this matrix has been reordered to best show the structure in the results.
The Aggressive patients separate out from the other two groups, which confirms
our intuition, given that their prognosis is so different from Healthy subjects and
Indolent patients. Indolent and Healthy, which are expected to be more closely re-
lated, are often clustered together. This provides some basis for believing that there
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Figure 4-2: Hierarchical clustering, where the the data is comprised of subpopulations
of subjects, which in turn are comprised of waves of genes
are differences among the subject groups that can be identified, but is not entirely
satisfactory because the subset of 1028 genes used for clustering were selected based
on consistent within-group behavior. Addressing this issue requires simultaneous
clustering of genes and patients.
4.3 Hierarchical formulation
Combining patient clustering and gene classification into an integrated approach is
accomplished by adding an additional level of hierarchy into an EM formulation,
which is shown in the diagram in Figure 4-2. We assume that there is an underlying
distribution of patients, which each have an underlying distribution of genes. The first
layer of the hierarchy remains the same as the clustering of subjects in the previous
section, but p(XIc, 8) becomes:
MN
p(X c, E) = p( I p m, O)p(mr n, c, E), (4.8)
m=1 n=l
where n specifies the gene and m specifies the gene model. Therefore, the complete
data likelihood function is now:
C P MN
L()) = 5 1 p(c p, E)) H p(XnpIm, E)p(m n, c, o) (4.9)
c=1 p=l m=1 n=1
I
VI;;·No -:-i
The probability for a given gene F, in a given class is defined by:
T
p(Iplm, ) = f p(Xnptlm, ) (4.10)
t=1
Unlike the formulation in 3.2.2, it is no longer necessary to take a product over patients
because the patients are combined in the first, level of the hierarchy. However, the
rest of the formulation is almost identical. We also assume for now that the gene
model parameters are shared across patient clusters, which means that the size and
shape of the expression profiles are the same, and it is the wave labels that differ. For
waves 1 through 4, the "dominant" time point is defined as being strictly positive,
which corresponds to an increase in gene expression at that time point due to the
initial stimulation. When m (the class label) corresponds to t (the time point), the
equations are:
p(xnptlm, O) = A,m exp (-Am,,npt) for xnpt > (1 (4.11)
p(Xnpt m, ) = 0 for znpt < 0 (4.12)
At the other time points, the two-sided Laplacians are defined by:
p(xnpt m, -) = exp (-Amt+xnpt) for Xt > 0 (4.13)
p(xnptm, 8) = exp (At-xnpt) for npt < 0 (4.14)
The parameters for the distributions at the non-dominant time points are Amt+, which
are unique to each model and expected to be larger (modeling smaller deflections)
than A,,m., and At-, which are shared across the four wave models. Because these
parameters are shared, the negative deflections will be equally likely under each of
the models and will not have an impact on the assignment of a gene to a particular
class. The final class is the background, which is composed of genes that are not dif-
ferentially activated with BCR, stimulation and are modeled by a zero-mean Gaussian
distribution at each of the four time points.
P(xnpt m, ) = ex1 -xnt (4.15)V`2r ep ,2
The difference between this formulation and the one for the wave clustering presented
in Chapter 3 is in how the information across subjects is combined. Instead of a fixed
assignment of a patient to a group, where each patient is assumed to be an indepen-
dent draw, the patient cluster assignments are iteratively adjusted depending on the
consistency of the wave labels of their genes. In the Expectation and Maximization
steps, we show how the parameters of the distributions and the class memberships of
each gene and patient are estimated.
4.3.1 EM iterations
In the Expectation step, we define:
Wnmpc = p(c, m| np, )k) (4.16)
This is the joint posterior probability for a gene model m and patient class c for a
given gene n for a given patient p. It is computed by:
p(x np c, m, Ok)p(c, m n, p, ek)Wnmpe pC n(4.17)
c/=1 Em'=l p(c', m'Jn, p, O k)
In the Maximization step, the update equations for parameters are very similar to
those in Chapter 3.
C P -kN 2
r2 _ C=1 Z= 1  =1 Wnmpcxnpt (4.18)
C- = 1 p=l n= Wnmpc
The remainder of the parameters are for the wave classes. For Am., the peak time
point, when m = t:
A2-- E c=1   =1 EnEx7 ,pt>O WnmpcXnpt (4.19)
Ec=1 Ep=1 ZnExpt>0 Wnmpc
Instead of summing over all N genes, only those with xpt > 0 are included. Currently,
we impose a hard constraint on Am., which guarantees large positive deflections at
the cluster's peak time point. For the non-dominant time points, when m Z t:
•2=l p=l =1 nEnpt>O Wnmpc np
t
mt+ ZI = n p >O nt (4.20)
c=1•=1 nExnpt>O nmpc
For the shared parameter At-:
C C=I Z• 1 EP nExnpt<O Wnmpc Xnpt
A- C M-1 P (4.21)
c=1 Zm=1 p=1 nnEXnpttO Wnmpc
It is important to note that because we sum over C, the model parameters A
and a are shared across the patient classes. This implies that the shapes of the
genes are expected to be relatively consistent across patient classes, which given
the cluster means shown in Figure 3-10 is a reasonable assumption. With shared
parameters the discrimination between patient classes occurs with which model the
genes were assigned, not the shapes of the models. If the model parameters were
different depending on the patient cluster, the only difference in the formulation would
b)e that there would be no summations over C and parameters would be computed
indep)endently for each class.
In computing the mixture proportions, we weight each gene's contribution to the
model as before, but we also weight the contribution of the patient, according to its
patient cluster membership. For these updates, p(c, mjn, p, ek) can be reduced to:
p(c, mjn, p, (k) = p(m- n, c, Ek)p(clp, Ek). (4.22)
Each of those is computed by:
N 1 IM
p(cJp, ek) Zn=1NZ m=1 Wnmpc (4.23)
c/=1  ,n=1 4m=1 Wnmpc
and
p(mln, c, o()k) P=1 Wnmpc (4.24)
m'= 1 Ep= 1 Wnmpc
These are two extremely useful values in understanding the clustering results. The
first, p(clp, Ek), provides the posterior probability for a cluster given a patient and
the current parameter settings, which is used for the MAP assignment of a patient
to a cluster. The second, p(mln, c, gk), is used for each gene's MAP assignment to a
gene model within a patient cluster. It is represented by a M x 1 vector that is the
mixture proportion for each gene model. When there is only one non-zero value in
that vector, that gene has the same label for every patient in the patient cluster. If
all the values were equal, the wave label would be completely inconsistent within the
cluster. Therefore, the maximum of p(mln, c, -) for a given gene and cluster provides
measure of consistency that ranges from L to 1. As we evaluate the quality of the
clustering, measuring consistency of the labelings within the cluster is key.
4.3.2 Initialization
Cluster parameters are initialized in the same way as in 3.2.2, using an ML estimate
of the parameters for an appropriate subset of the data at each time point. For the
mixture proportions:
p(cIp, W0 ) -= 1, (4.25)
where e1 is a small random perturbation.
p(mJn, c, 90 ) = E2  for m < M, (4.26)
p(mln, c, 0° ) = 1 - (M - 1) x C2 for m = M (4.27)
where 62 is the approximate fraction of genes in each wave class.
4.4 Results on synthetic data
We first test the ability of the algorithm to label genes and patients simultaneously
where the underlying structure of the data is known and is similar to that of the BCR
data. In this toy example, we generate expression profiles over 4 time points for 100
genes and 8 patients. The distributions from which the expression profiles are drawn
are parameterized by the variance, a2t for zero-mean Gaussians, defined at each time
point so the shapes roughly correspond to a background class and four wave classes.
To divide the data into two relatively consistent patient groups, the genes for
half the subjects are randomly reordered. Now, for example, gene 1 could have been
drawn from the wave 1 distribution for half the patients and drawn from the wave 2
distribution for the other half. The resulting data set is shown in Figure 4-3, and no
visual structure is evident.
Timel Time2 Time3 Time4
Figure 4-3: Synthetic data for 100 genes and 8 subjects, grouped by time point
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Figure 4-4: Reordering of the synthetic data given the clustering results. The order
of the genes is different for clusters 1 and 2.
4.4.1 Cluster structure
We run the hierarchical clustering with the update equations formulated to estimate
the oa, of the zero-mean Gaussians. Given the MAP assignments of the patients to
patient classes, and the MAP assignments of the genes to gene models, we reorder
the data to show the cluster structure in Figure 4-4.
This shows, for a small example, that hierarchical clustering successfully recovers
the structure of the data. Visually, it appears the the patients have been divided
into two clusters in which all the genes have been labeled in a meaningful way. In
order to confirm the intracluster consistency quantitatively, we compute the maxi-
mum p(mln, c, Ok) for each gene in each cluster. As previously discussed, this ranges
from 1 (uniform distribution over all possible labels) to 1 (completely consistently
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Figure 4-5: Histograms of the maximum p(mln, c, 6) values for each gene in each
cluster
labeled). Histograms for the two clusters are shown in Figure 4-5. For nearly all the
genes, the labeling is completely consistent within a cluster. The mean values for the
distributions of each of the two clusters are 0.9761 and 0.9663, respectively.
4.4.2 Cluster separability
In the actual data, we expect some number of genes to be at least as consistent
across groups as they are within groups. Not all genes would be expected to behave
abnormally in the B-CLL patients, and microarray data is noisy. If the number
of genes important to B-CLL is small as compared to the number responding to
BCR stimulation, then one would not expect a hierarchical approach to necessarily
correspond to clinically relevant subpopulations. In order to determine how separated
two groups have to be in order for the clustering to converge to a consistent, accurate
result, we vary the fraction of genes that are reordered for the second patient cluster.
That is, when we only reorder 10% of the genes, 90% are drawn from the same
distribution and should be labeled in the same way in both patient groups. This is
obviously a more difficult clustering problem than the previous one in which all the
genes were reordered. To measure the success of the clustering, we record the number
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Figure 4-6: Iterations required for hierarchical clustering to converge as a function of
the fraction of genes reordered to separate the two clusters
of iterations required to converge to a set criterion. At each fraction, we re-run the
algorithm multiple times to average out the effects of initialization.
Figure 4-6 shows that as the fraction of genes reordered increases, the number of
iterations required decreases. As expected, as clusters are more separated by increased
amount of reordering, the algorithm is able to converge more quickly to the correct
result. It is interesting to note, however, that even for as few as 5-10% of the genes
differing across clusters, the patient groups are still accurately identified. This means
that the algorithm is able to ignore the irrelevant information, and while the actual
data is still much more challenging, it does show that this layered approach works
when we know that our initial modeling assumptions were correct.
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Figure 4-7: Affinity matrix for 17 subjects showing how often each patient pair was
clustered together over the 20 trials of hierarchical clustering
4.5 Results on BCR data
To cluster the data from the BCR data set of 17 subjects, we set C = 3, expecting to
recover clusters similar to those in 4.2. With shared model parameters and random
initialization over 20 trials, we compute how often pairs of patients were clustered
together. This is shown in Figure 4-7, where the affinity matrix has been reordered
according to pairwise similarity. There is structure; however, as was pointed out in
[82], a "successful" clustering result is not necessarily biologically meaningful. In the
image, we see a mix of subjects from each of the patient groups in each block of
structure. This suggests that the hierarchical clustering found structure in the data
that corresponds to these unexpected groups. By looking at the histograms in Figure
4-8(a), we see that there is a reasonable amount of consistency in the gene labels
within a cluster. The means are values are 0.6742, 0.8866, and 0.6356 for each of the
three clusters. To have a basis for comparison, we re-ran the hierarchical clustering
algorithm with the patient assignments fixed to the Healthy, Aggressive, and Indolent
clinical labelings. We then compute p(mln, c, Ok ) again, and these histograms, shown
in Figure 4-8(b), are shifted slightly left compared to the hierarchical results, with
mean values of 0.6430, 0.7076, and 0.6469.
Of particular interest here is that the "actual" assignments show labelings that
are no more consistent than the hierarchical clustering. It appears that multiple
subdivisions of the subject populations are relatively consistent, and that the results
for each trial vary, depending on the initialization. There are several potential reasons
that the clinical breakdowns do not show greater consistency across subjects. The
first is that the microarray data is too noisy, and there are simply too few subjects to
accurately determine what each gene should be labeled. The second is that the groups
actually are heterogeneous, i.e. more patient clusters are necessary to represent the
data well. Finally, perhaps group differences are not captured by the differences
in gene labeling but in difference in the wave model parameters. Unfortunately,
again given the very limited number of subjects, when the model parameters are not
shared across patient clusters, there is not enough data to support the number of free
parameters and clustering fails entirely. For the purposes of this work, this is the only
data set of its kind available, and until more subject data is collected, it is impossible
to identify which of these potential issues is the reason for the unexpected clustering
results. Therefore, in the analysis of the clustering in Chapter 3 and the inference of
the predictive models in Chapter 5, we continue to use the clinical labelings.
4.6 Summary
In this chapter, we have presented a hierarchical EM approach to a biclustering prob-
lem, in this case the simultaneous assignment of genes to wave classes and subjects to
patient clusters. While clusters embedded in a synthetic data set are successfully re-
covered, even with a small fraction of genes that differentiate between the two patient
groups, it is less successful for the BCR data set. It does classify subjects into groups
that show consistency wave labelings across genes, but these do not correspond to
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Figure 4-8: Histograms of the maximum p(m n, c, ek) values for each gene in each
cluster
the Healthy, Aggressive, and Indolent subgroups. For that reason, we do not use an
integrated approach in the clustering of the genes or the inference of the predictive
models described in Chapter 5.
Chapter 5
Predictive Modeling
A key goal in understanding the behavior of cells and the effects of genetic differences
is the reconstruction of networks of interaction. This has become more practical
as recent DNA microarray technologies have made it possible to monitor transcrip-
tion levels of tens of thousands of genes in parallel. Treating mi:croarray data as a
large collection of traditional experiments that simply need to be processed in an
automated way ignores one of the key advantages. Global measurements allow us
to search out patterns of expression and relationships between genes. By combining
confirmatory results, which simply show that microarray analysis is consistent with
expected behavior from the literature, and new results, we begin to form a more
complete picture of what is occurring in the cell. Due to the complex procedures
of microarray experiments, gene expression data often contains a large amount of
noise. Additionally, while DNA microarrays enable measurement of the transcripts
of every gene, we cannot measure protein expression levels or biochemical activity of
gene products. These are, generally, what are actually physically interacting with one
another and functioning in the cell. A comprehensive picture of the transcriptional
regulatory network would require direct measurements. There is, however, a sensible
link between the expression pattern and function of the gene product [9]. Therefore,
while predictive models may show relationships between mRNA expression levels,
these do not necessarily correspond to actual, physical interactions of RNA sequences
or proteins.
There are three major challenges in inferring the predictive networks. The first
is that even given the subset of the original data, clustered in Chapter 3, there are
still many times more samples (genes) than there are observations (time points and
subjects). We address this by imposing sparsity on the networks in several ways.
The second is that it is not clear how to take into account temporal interactions,
which we are able to do because of BCR stimulation and the acquisition of time
series data. Finally, evaluating the quality of the resulting models is difficult. In
addition to simply visualizing the networks, we perform leave-one-out cross-validation,
analysis of network structure, and tests of robustness and statistical significance. Once
the models are inferred, we identify genes for literature comparisons and biological
validation experiments, which are discussed in Chapter 6.
5.1 Background
The most popular method for inferring the relationships between genes is to build
coexpression networks. A variety of experimental conditions, gene deletions, or even
species profiles [68] are used to determine which genes behave in similar ways. Prob-
abilistic graphical models and Bayesian methods [28, 35, 38, 41, 60] are common.
One drawback for much of this work is that while it is effective for small numbers of
genes [4, 88, 89] or when the transcription factors are already known [63], it becomes
computationally impractical as the number of genes increases. The complete tran-
scription regulatory network has been built for yeast [3, 75], but even for a relatively
simple organism like Xenopus, networks are still largely unknown [43].
More importantly, a coexpression network as typically viewed is not our goal. In-
stead of linking genes that behave similarly under set experimental conditions, we
attempt to link genes that influence one another across time. Relationships between
transcription factors and targets are more complex than coexpression. These relation-
ships may be inverted or time-shifted [85]. Bickel et al.[6] introduce the concept of lag
in time to the co-expression network, and more complicated temporal relationships
are explored by Guthke et al.[34] and Tabus et al.[71].
Relevance networks inferred by Reis et al. [58] utilize dynamics in gene expres-
sion data in addition to static coexpression in order to take into account effector
(enhancer/suppressor) type relationships. Darvish et al. [21] relate future expression
levels of prototypes of gene clusters to past expression levels of each of the prototypes
of each of the clusters to each other. Both of these methods use a yeast gene expres-
sion data set with a relatively high sampling rate in time. Yeast is often used as a
model organism for studying transcriptional networks because it is easy to manipu-
late experimentally and has a relatively small number of genes, most of which are
functionally annotated. Our BCR data set, however, includes an order of magnitude
more genes and subjects from a variety of genetic backgrounds.
5.2 Inferring models of interaction
Ideally, we would like to infer relationships between every possible gene pair as:
N
j +j ( (5.1)
i=1
where 'j is the vector of differential expression levels (each element corresponding
to a time point) for the jth gene, ijo() is a function which models the influence of
gene i on gene j, and 77 is an additive noise term. Given limited data, care must
be taken in the parameterization of such a model. Even for linear models, allowing
independent relationships between every possible gene pairing would require inference
of N2T2 parameters from N x T x P data points. We therefore specify a number
of simplifying constraints resulting in a tractable inference procedure. While it is
reasonable to question any of these choices, they are supported by the subsequent
empirical results.
In our model, we divide interactions, represented above by ij(), into two pieces.
The first is the mode of interaction Fk(i)k(j), which models relationships of excitation,
inhibition, and differences in scale between input and output genes. Because the
wave assignments (as described in Chapter 3) classify genes according to temporal
structure, we use those labels to limit the number of modes of interaction. We describe
the additional structure of the Fk(i)k(j) matrices in detail in Section 5.2.1. Second,
wij represents the relative weight (between 0 and 1) of a prediction for a particular
predictor on an output gene.
N
= w FikO(i) (5.2)
i=l
The weight wij is re-parameterized as aij by:
w~ai (5.3)I i=1 aij
in order to define the global optimization:
sj*, {F}* = arg min Zj N Fij i (5.4)j,{F} Ei= 1 i 2
subject to the constraints:
a > 0 (5.5)
N
iE • 1 (5.6)
The reason for the constraints on a is that we expect that there are a limited number of
"input" genes that influence the expression of any one "output" gene, consistent with
biological literature. As the Fk(i)k(j) matrices already describe the type of relationships
over time between genes, e.g. inhibition, excitation, relative scaling, a values are
only used to define how strong are those relationships in comparison to all the other
possible input genes, so a negative connection would not be defined. The second
constraint serves as an L1 penalty imposing sparsity on the number of incoming edges.
The most important advantages of L1 penalization schemes are their convexity, and
the strong sparsity of the results, in that most indices of the result are set exactly to
zero [49]. An equivalent form of these constraints on a is provided in Section 5.2.2.
Global optimization of a and {F} simultaneously is non-convex; however, opti-
mizing the two sets of parameters is conditionally convex. If all the aij are known,
solving for Fk(i)k(j) requires a straightforward least squares calculation, and when the
set of F matrices is known, a solution for a is found using quadratic programming,
as implemented in MATLAB with the SeDuMi toolbox[69]. We therefore use coordi-
nate descent, a commonly used optimization technique, in order to iteratively solve
for {F} and a. Coordinate descent guarantees improvement of the objective criterion
on each iteration, and is guaranteed to converge to a stationary point [5]. In Sections
5.2.1 and 5.2.2, we further explain the two steps of the iterative procedure. For this
particular application, we found that for all three subject groups, this occurred after
approximately 6 iterations, which is what we used for all the analysis described here.
Upon completion, we have as output a connectivity matrix [a a2 1 ' . -N], which gives
us the strength of connection between genes, most of which are zero.
5.2.1 Wave interaction matrices
Using the labels assigned to each gene via wave clustering (see Section 3.2.2), we
limit the types of interactions between genes by computing common linear predictor
models indexed by wave type rather than allowing unique models for each gene-gene
pair. The intuition is that temporal structure as defined in the previous section is
a predictor of the way in which genes might interact. Consequently, wave 1 genes
are not predicted by anything, but are able to influence waves 2, 3, and 4. Similarly,
wave 4 genes do not predict any other waves, but are influenced by all other previous
waves. These relationships are characterized by six 4 x 4 matrices, F12, F13, F14, F23 ,
F24, and F34, where the first index represents the input wave type and the second
represents the corresponding output wave type.
Regardless of which wave the gene belongs to, all F matrices are lower triangular,
enforcing temporal causality. Dependencies that span the same number of time steps
have the same coefficient. This is equivalent to saying that the effects of a given
gene will be stationary, influencing other genes in a consistent way over time. For
example, if the gene excites the expression of the output at the immediately following
time point, this will be true for t1-t 2, t2-t3, and t3-t4 . The gene may, however, have a
longer term inhibitory effect for other time point pairs. Because the time points for
this data set were not evenly sampled, these are not quite stationary relationships, but
these requirements balance simplicity of the model and our reasonable expectations of
protein and gene interactions with the flexibility required to represent more complex
relationships. For a single input-output pair of genes F and ', which are each a 4 x 1
vector, the F matrix is the linear transformation:
Y1 0 0 0 0 xl
Y2 a 0 0 0 x2
+ (5.7)
Y3 b a 0 0 X3
Y4 c b a 0 x4
As an initial estimate of the models, we group genes by wave type. Given Ninput
genes of the input type and Noutput genes of the output type, there are Ninput x N tput
possible combinations of these genes that need to be accounted for enumerated as:
Y11 Y12 .'" Y1No.utput 0 0 0 0 X1 1  11  "" XlNi,,pUt
Y21 Y22 "'. Y2Noutput a 0 0 0 x21 x21 ... X2Ninput
Y31 Y32 "'" Y3Ntpt b a 0 0 x31  X31 1 X"" 3Ni•put
Y41 Y42 "" Y'4Nout,pt c b a 0 X41 X41 X' • 4Ninput
Fk (input) k (output)
(5.8)
where X, Y E C x(Nipu, xNoutput) with the genes ordered in such a way as to enumerate
every possible pairing. The parameters a, b, and c are estimated by minimizing the
following least squares criterion:
{a, b, c} = arg min lY - Fk(input)k(ouput)(a', b', c')X11 2  (5.9)
al,b',d'
after reshaping the data into vectors and computing each element of Fk(input)k(output)
independently. This is equivalent to having all connection strengths aij set equal to
one another, which is used only for the initialization. After the first iteration, using the
a vectors resulting from the optimization in Section 5.2.2, we re-weight the matrices
according to the strength of the connections, then re-estimate the Fk(input)k(output)
matrices as:
{a, b, c} = arg min IY' - Fk(input)k(output)(a', b', c')X' 1 2  (5.10)
a',b',c'
where Y' and X' include all possible input and output pairings, scaled by the corre-
sponding aij.
5.2.2 Combining predictions
For a given output gene xj, we use a weighted combination of the predictions, repre-
sented as:
di = arg min - Z ,Fk( kJ (5.11)
subject to the constraints:
ai > 0 (5.12)
N
Saj • 1 (5.13)
i=l
where k(i). k(j) are the wave labels of gene i and gene j, respectively, and aij > 0 is
their connection strength. An equivalent form would include the L 1 penalty on 'j in
the minimization as:
; = arg min -Z Fk(i) + ai (5.14)
ad Ei=1 2j
still subject to the constraint:
aij > 0 (5.15)
The relative weighting A of the L1 norm and the L2 norm of the prediction error can
also be varied to adjust sparsity as the two are minimized simultaneously. This would
be similar to adjusting the threshold on the L1 constraint in the equivalent form in
Equation 5.13. For either of these forms, we solve for a using quadratic programming,
as implemented in MATLAB with the SeDuMi toolbox[69].
5.3 Visualization
Visualization of inferred networks is difficult because of the number of genes and the
dynamic nature of the expression profiles and the interactions. We use Cytoscape
software [65], and in Figures 5-1, 5-2, and 5-3, we show a default layout in which
edges of the graph correspond to springs, creating an attractive force between nodes
that are far apart, and a repulsive force between nodes that are close together. Each
node actually represents the entire temporal expression profile of the gene, and each
edge represents a 4 x 4 matrix Fk(input)k(output) and the connection strength aij between
the two genes. As the nodes in the network are arranged in this way, we see that there
a small number of genes in each network that have a very large number of outgoing
edges. The network structure is described in more detail in Section 5.4.1.
In order to represent the dynamic networks statically, we show in Figure 5.3 the
progression through waves of expression, which is related to time. Though a single
node still represents the expression profile over 4 time points for that gene, we use the
cluster labels of the genes, which corresponds to the time point at which they peak,
to show which genes and which interactions dominate at a given time. In the leftmost
column Figure 5.3, the wave 2 genes are highlighted in yellow. They are influenced
by wave 1 genes only, via F12. These connections are shown in red. In the center
column of Figure 5.3, wave 3 genes are highlighted, and inputs that are direct (those
from wave 2, which is only one time step removed) are shown in red, while inputs
that are from wave 1 to wave 3 are shown in blue. Finally, in the rightmost column
of 5.3, wave 4 genes are highlighted, with direct connections from wave 3 genes in
red, inputs from wave 2 in blue, and inputs from wave 1 in green. Red connections
appear to dominate the network, consistent with the assumption that genes are most
likely to effect genes in the immediately following wave, even though this was not an
explicit constraint. This is shown qualitatively here, but is confirmed quantitatively
in Section 5.4.1.
5.4 Analysis
As explained in Section 5.1, inferring the networks, while challenging, is merely a
starting point. From a mathematical standpoint, the network results can be evaluated
in several ways. The first is the structure of the network, which includes the number
and types of edges, as well as the parameter values. In addition, we evaluate the
robustness of the edges of the network to input noise. Finally, using accuracy with
respect to prediction error, we compute statistical significance and leave-one-out cross
Figure 5-1: Network inferred for healthy subject group
99
Figure 5-2: Network inferred for aggressive subject group
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Figure 5-3: Network inferred for the indolent subject group
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validation. None of these depend on local validation of the networks from biological
experiments, which will be discussed in Chapter 6.
5.4.1 Structure
Each edge represents the link between two genes: there is the Fk(input)k(output) matrix,
which depends on the wave labels of the input and output genes, defining the pre-
dictive relationship over time, and there is the a weighting that defines the strength
of the connection. We first describe the effects of the iterative method for adjusting
the interaction matrices, then quantify the types of interaction matrices that make
up the networks, and finally discuss the effects of varying the sparsity constraint on
aj, the number of edges present.
Wave interaction matrices
As described in Section 5.2, there are two methods for computing the Fk(input)k(output)
matrices, which are wave-specific modes of interaction. The first computes the least
squares estimate of the matrix elements weighting all possible input/output pairs
equally. The second iteratively adjusts Fk(input)k(output) and a according to a coordinate
descent method that decreases the prediction error. The prediction error for the
network converges with the re-weighting of the input/output pairs according to a in
the computation of Fk(input)k(output) at each iteration. For all three subject groups, the
error stops decreasing after approximately 4 to 6 iterations. There is some variation
in when this happens, depending on the subject group, but because of computation
time considerations and in order to have a set number of iterations for all further
analysis, we use the adjusted Fk(input)k(output) matrices and a values after 6 iterations.
We compare the error in Table 5.1. As the Fk(input)k(output) matrices are optimized,
there is guaranteed to be an improvement in the prediction error scores. For each
network, we see about a 15% to 20% decrease in the prediction error. In Figure
5-5(a) and 5-5(b), we compare the values in the Fk(input)k(output) matrices before and
after the optimization. In the adjusted matrices, a, b,and c are generally higher than
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Table 5.1: Prediction Error with adjusted and unadjusted F matrices
Unadjusted F Adjusted F
Healthy 167 139
Aggressive 140 108
Indolent 170 135
their unadjusted counterparts because the unadjusted values are influenced by input-
output pairs of genes that are not related to one another. These pairs will, in general,
average one another out, leading to no clear activation or inhibition relationships.
During optimization, these gene pairs have less of an impact in the estimation of
Fk(input)k(output) because of their low connection strengths. Therefore, the larger values
of a, b, and c are from the consistent relationships between the waves. The reason for
the very high value of c in F24 for the Healthy subject group is unknown.
Edges
We see qualitatively in Figure 5.3 that there appear to be many "red" edges. These
edges correspond to F12, F23 , F34, which represent connections between adjacent
waves. We present this numerically as edge counts in Table 5.2, which shows that
the connections between adjacent waves (the first three columns of the table) do
in fact dominate the network. They comprise 80%, 78%, and 69% of the edges
in the Healthy, Aggressive, and Indolent networks, respectively. Interactions are
temporally local, which provides evidence of global waves of transcription in the
context of synchronized, isolated pathway stimulation.
A second element that was visually evident was the appearance of a small number
of genes with a large number of outgoing edges. In Figure 5-6, we show histograms
of the number of outgoing edges on a per gene basis. We define these as "hub" genes.
While the sparsity constraints on a are imposed to limit the number of incoming
edges to any one gene, the number of outgoing edges was not constrained. A total
of 18 genes (5 for Healthy, 7 for Aggressive, and 6 for Indolent) have more than 50
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Figure 5-5: Comparison of the adjusted and unadjusted F matrix parameters
Table 5.2: Edge counts
F12 F23 F34 F13 F24 F14
Healthy
Aggressive
Indolent
144 469 380 126 52
117 647 416 88 228 24
174 478 410 55 289 138
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Figure 5-6: Histograms of the number of outgoing edges on a per gene basis
outgoing edges. More than 90% of the genes have fewer than 10 outgoing edges.
In Chapter 6, we discuss what is known biologically about these genes and their
targets, as well as further experiments to validate the related parts of the networks.
This scale-free structure, however, is consistent with has been shown previously for
B-cell networks [4] and for transcriptional regulatory networks in general [8].
Varying sparsity constraints on alpha
We set the sparsity constraint on aj such that the L 1 norm was < 1 in Section 5.2.
We made this choice because we assume that all inhibition, excitation, and scaling
effects between input and output pairs are modeled with the Fk(input)k(output) matrices,
and aij values simply provide connection strengths. These connection strengths can
also be thought of as weighting the average contributions of the input genes. For
example, if one gene i is able to perfectly predict another gene j through the Fk(i)k(j)
matrix, without any contribution from any other input genes, then aij = 1 and all
other values in the aj are zero. In this case, a stronger constraint on the L 1 norm
(a lower threshold) would erroneously favor input genes that have larger predictions,
instead of those predictions which are on the same scale as the output gene.
We have, however, effectively adjusted this sparsity constraint up and down using
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Table 5.3: Significance
Prediction Error Min error p-value
Healthy 139 163 < 0.01
Aggressive 108 129 < 0.01
Indolent 135 167 < 0.01
the equivalent form in the optimization. As expected, as a more severe constraint is
imposed, the number of edges decreases. It would allow for greater control over the
sparsity of edges in the network if that is what is desired for another application.
5.4.2 Significance results
We test the statistical significance of the models that have been inferred using per-
mutation tests [56] in a method similar to the one in [6], where the false detection
rate of a connection between two genes in the model is calculated. We first define
a null hypothesis: there is no temporal structure in that data that can be repre-
sented with predictive models. To generate samples from this hypothesis, for each
trial, we randomly permute the time points for each gene independently (but con-
sistently within a patient group). Accurate p-values necessitate re-running the full
optimization (including wave clustering) because wave labels depend on the temporal
structure as well. While estimating a for the predictive models, the L2 norm of the
prediction error is minimized for each output gene. We sum over all the genes to get
an aggregate score for the network and the current data set for the patient group.
The statistical significance of our hypothesis that there is temporal structure in the
data is defined as the fraction of trials in which the permuted data has a better score
than the actual data.
In Table 5.3 and Figure 5-7, for all three subject groups, the error is lower in
all 100 trials given the original data for a p-value of < 0.01. This demonstrates
that labeling, model constraints, and connectivity constraints are not arbitrary. We
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Figure 5-7: Permutation histograms of prediction error for networks
conclude therefore that temporal structure exists and that it can be captured to some
degree by a small number of temporal structures and interaction types.
5.4.3 Stability
We test the stability of the edges in the network in order to show the robustness of the
inference procedure to noise for the networks in general and for specific subregions.
We model the effects of noisy microarray data by adding zero-mean Gaussian pertur-
bations (ranging from a=10 to a = 40, about an order of magnitude smaller than the
positive deflections of wave 1 genes) to the input data. For 25 trials, the networks
are re-estimated using the same subset of genes that had been previously identified
and labeled by the wave clustering. In Figure 5-8, we show "survival curves" for
consistent edges. As a function of the number of trials, these curves are computed
from the fraction of edges in the original network that are present. Virtually 100%
of the edges each of the original networks are present in at least 1 trial. However,
anywhere from 15% (Healthy, a = 40) to 80% (Aggressive, a = 10) are present in all
25 trials. The Aggressive subject group seems to be more consistent than the other
two groups, likely because there are only five patients in the group as opposed to six
for the other two groups.
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Figure 5-8: Stability of the edges for all three networks with differing levels of noise
added to the input data.
We show these figures to give a general context for how the entire networks behave,
so we can compare these results to those for subnetworks. We identified in Section
5.4.1 a small number of "hub" genes that have a large number of outgoing edges,
which we expect to play an important role in the networks. In Figure 5-9, we display
survival curves for the outgoing edges of the hub genes compared to the average curves
for the networks (a = 20, which is a representative result for the other values of a).
In nearly all cases, the outgoing edges of the hub genes are more consistent than the
averages. Because the outgoing edges associated with the hub genes are more stable
than the networks as a whole, they are less likely to have been produced at random,
and therefore provide a starting point for biological validation of the networks.
5.4.4 Cross validation
In this section, we perform leave-one-out cross validation to test the consistency of
the networks within and across subject groups. We use a single subject from the
original data set as the testing data, and the remaining observations as the training
data. We repeat this such that each subject is used once as the testing data, held out
from the inference of its own type of network (healthy, aggressive, or indolent). For
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Figure 5-9: Stability of the edges for the hub genes as compared to the non-hub genes.
example, for subject Healthyl, the Healthy network was inferred using the data from
subjects Healthy2 through Healthy6. Using the input data for Healthyl, we compute
the aggregate prediction error for that network as well as the prediction error for the
network inferred from all the Aggressive subjects and the network inferred from all
the Indolent subjects. The results are shown in a bar plot in Figure 5-10.
For four of the six healthy subjects, the healthy network has the lowest prediction
error. For three of the five aggressive subjects, the aggressive network has the lowest
prediction error. For five of the six indolent patients, the indolent network has the
lowest prediction error. If we were to use the cross validation results to classify
subjects into groups, it would be marginally successful. This implies that even within
groups, there is inconsistency across patients. Some of the inconsistency can be
attributed to the noisiness of the microarray data, but we also expect that genetic
differences play a role. Particularly for the B-CLL patients, as was explained in
Section 2.1.2, groupings based on disease outcome or on various genetic mutations
yield different results. Because our data set includes such a small number of patients,
outliers are not only not well-classified but also bias the networks in which they are
included.
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5.5 Summary
In this chapter, we have introduced a method for inferring sparse models of temporal
interaction for genes relevant to the BCR signaling pathway using the wave cluster
labels from Chapter 3, which have a consistent biological interpretation, to define a
small number of modes of interaction between the genes and by effectively limiting
the number of genes influencing each target gene. In order to represent the dynamic
networks statically, we show in Figure 5.3 the progression through waves of expression,
which is related to time. We first describe the effects of the iterative method for
adjusting the interaction matrices, then quantify the types of interaction matrices
that make up the networks, and finally discuss the effects of varying the sparsity
constraint on 5a the number of edges present. We test the statistical significance
of the models that have been inferred using permutation tests. This demonstrates
that labeling, model constraints, and connectivity constraints are not arbitrary. We
conclude therefore that temporal structure exists and that it can be captured to
some degree by a small number of temporal structures and interaction types. Also,
in nearly all cases, the outgoing edges of the hub genes are more stable than the
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averages of the networks as a whole. We perform leave-one-out cross validation to
test the consistency of the networks within and across subject groups.
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Chapter 6
Biological Implications
In Chapters 3 and 5, we presented the results of clustering and predictive model infer-
ence from a mathematical perspective. We have shown that the temporal structure
of the data has been successfully captured, but the purpose of the modeling was also
to provide insight into the genetic program of the B cell receptor signaling pathway.
The ultimate objective is to use the network to design different approaches for affect-
ing the evolution of the gene activity profile of the network [25]. In a disease-specific
sense, analysis of the differences in the networks between healthy subjects and B-CLL
patients could eventually guide potential treatments.
Therefore, from a biological standpoint, we first validate the networks that were
inferred and then use the networks to design future experiments. Validation is done
in three ways: 1) comparisons of the genes that play important roles in the network
to those that have been previously determined to be relevant to BCR activation or
B-CLL, 2) comparisons of the links in the network to known physical interactions,
and 3) most importantly, intervention experiments that test network predictions by
overexpressing or silencing a gene. This third method distinguishes between causality
and correlation in local regions of the network. For example, if two genes are regulated
by a common factor, with its effects on one lagging in time as compared to the other,
the former may appear in the network as having been influenced by the latter (either
in addition to or instead of the common factor). Intervention experiments tease out
these differences, as only genes that are actually influenced by the manipulated gene,
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either directly or indirectly, will show substantial and predictable changes as compared
to the control. Because of the relatively large number of genes in the networks (500
per subject group), one important issue is still gene selection and the question of
how we can take advantage of the structure of the networks and the cluster labels to
identify genes to target.
We also compare the clustering results across the three subject groups. As was
explained in Chapter 4, there is not adequate consistency within the current subject
groups to combine clustering of genes and subjects in an integrated approach, which
was the reason we used the known clinical labelings (Healthy, Aggressive, Indolent).
We do, however, analyze aspects of the clustering results to determine how cluster
labels relate to subject group and to combine the networks into a single visualization.
6.1 Network structure
While sparsity constraints imposed during the predictive model inference procedure
(see Section 5.2.2) limited the number of incoming edges to any one gene, the number
of outgoing edges was not constrained. In Figure 6-1, histograms of the number of
outgoing edges per gene show that the inferred networks have a scale-free structure.
This is consistent with what has been found in protein interaction networks [8], where
a small number of proteins serve as hubs for very large numbers of interactions. A
transcriptional regulatory network, which was inferred from a large set of expression
profiles that represented perturbations of B cell phenotypes, shows similar structure
[4].
For each of the three subject groups, more than 90% of the genes have fewer than
10 outgoing edges, and 18 genes (5 for Healthy, 7 for Aggressive, and 6 for Indolent)
have more than 50. We define these as "hubs". From Section 5.4.3, when perturbing
the input data with noise, the edges related to hub genes are more consistent than
those in other regions of the networks. These hubs appear to not only be important to
the network predictions, but their connections to their targets are relatively stable as
well. They therefore provide a starting point as candidates for literature comparisons
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Figure 6-1: Histograms of the number of outgoing edges on a per gene basis
and for further experiments. In the following section, we investigate these highly
connected genes.
6.2 Hub genes
The probe set labels for the 18 network hubs represent 15 known genes. Of these,
EGR1, NR4A1, and ZFP36 are already known to be expressed after BCR stimulation
[64, 52]. Those three genes, in addition to the hubs BTG2, CXXC5, and NR4A3, are
transcription factors [51], which by definition are genes that influence others. Each
transcription factor stimulates the transcription of target genes through the binding
to specific DNA regulatory element located at the beginning of each target gene. The
number of possible binding sites through the genome is different for each transcription
factor, ranging anywhere from fewer than 200 to more than 10,000, depending on the
network [79]. It is important to note that because the networks are only inferred
relationships and not necessarily actual physical interactions, identification of hubs
in the network that are known transcription factors is a confirmatory result.
Table 6.1 shows the complete list of the probe set labels for the hubs identified
in the networks, with the threshold on the minimum number of outgoing edges set
at 50, for each of the three subject groups. We also include the gene name [80], if
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it is known. In addition to the transcription factors (in bold), these genes code for
motor proteins (DNAH3), ribosomes (RPL1OA, RPL15, RPL27A, RPL37A, RPS27),
transport proteins (SLC2A3), and enzymes (SAT) [48].
As we have established that a number of the network hubs are transcription fac-
tors which could potentially have influence on target genes, we compare individual
links in the network to potential physical interactions. For other BCR-related subnet-
works, Basso et al. [4] validate around 40% of inferred connections using chromatin
precipitation (chIP-chip) experiments, so we do not expect perfect correspondence.
In our case, the links in the network could be a result of the modeling decisions
made to make inference tractable, artifacts of noise in the data, or could appear to
be direct connections when the gene actually acts on the target indirectly through
an intermediate transcription factor. As there is not yet ground truth for all possible
interactions, regions of the network are analyzed manually. We begin with the sub-
network associated with EGR1, a hub in the Healthy network with 93 outgoing edges.
The probe sets corresponding to these edges represent 76 different known genes. We
compare the inferred links in the network to actual potential physical interactions by
searching for the EGR1 binding site in the promoter region of these putative target
genes using the TESS database [62]. Of the 93 potential target probe sets, 37 have a
binding motif for EGR1. This confirms that EGR1 may in fact be acting directly on
some of the targets to which it is linked in the network, despite having inferred the
relationships based on only the mRNA expression profiles.
As this analysis is completed for the remaining hub genes, we will lower the thresh-
old for outgoing edges in order to identify more genes for further research and experi-
mentation. Figure 6-2 shows how the number of genes that would be selected changes
as a function of the threshold. Gene selection is an important problem in microarray
analysis, given that it is simply not possible to test every possible interaction exper-
imentally, so our results guide experimental design based on which genes appear to
be related statistically. For the hubs in particular, we have greater confidence in the
stability of those local regions of the networks and the potential for physical interac-
tions, which we can then provide to the biologists to investigate in a systematic way.
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Table 6.1: Hub probe set labels and corresponding gene names (transcription factors
in bold)
Probe Set
220725x at
201693_sat
216236-sat
229563-sat
230333_at
Name
DNAH3
EGR1
SLC2A3
RPL1OA
SAT
200741_sat
201236_sat
203034s_at
214041 xat
222145_at
224516_sat
227404_sat
216979 at
227224_at
221475s-at
201531 at
202340_x-at
238276_at
RPS27
BTG2
RPL27A
RPL37A
unknown
CXXC5
EGR1
NR4A3
R.ALGPS2
RPL15
ZFP36
NR4A1
unknown
117
140
120
100
.)
CD
-c 80
-0
E
z
40
20
n
0 50 100 150 200 250
Number of Outgoing Edges (threshold)
Figure 6-2: Number of hub genes selected given the threshold on the number of
outgoing edges
6.3 Sensitivity analysis
Once the networks have been inferred, testing the predictions is the obvious next
step. One way to do this is to manipulate the expression levels of a single gene, either
by silencing or overexpression, in an intervention experiment. These intervention ex-
periments are expensive and time-consuming to perform because as we test temporal
interactions, time series acquisitions are necessary. Therefore, much thought must go
into selecting the target gene. It should peak early in the BCR activation response, so
that it will have downstream effects in the cascade of reactions that can be measured
over the time course of the experiment. It also should be expected to influence many
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other genes, so model predictions can be compared to actual measurements. Identi-
fication of genes with these two properties are precisely what wave cluster labeling
and the inference of the predictive models provide. First wave genes (as labeled in
Cha~pter 3) are, by definition, those that peak early in the response. Hub genes in
the networks (as inferred in Chapter 5) have many direct connections, presumably
to target genes they influence. However, in order to be more general, we take into
account both the direct and indirect connections in this section.
In order to identify potential target genes, we propagate the effects of manipulation
of each of the first wave genes for all three of the networks. This is more complex
than simply computing all the predictions, as we also include the indirect effects. For
example, a first wave gene may influence second, third, and fourth wave genes directly,
but the second and third wave genes that it influences may also have connections to
other third and fourth wave genes. More precisely, for a first wave gene xi, second
wave genes xj are connected only directly:
Mx = ajjF12 i (6.1)
Third wave genes Xk are connected directly to -4 via the interaction matrix F1 3 and
indirectly through second wave genes:
Xk = aik F13 i (6.2)
+ Z ajkF23aijFl2xi (6.3)
jEw2
Fourth wave genes Yz are connected directly to £x via F14 and indirectly through
second wave genes, third wave genes, or both:
x1 = ali F 14 i (6.4)
+ E aliF 24ajF 12 'i (6.5)
jEw2
+ E akIF 34aikFl3Xi (6.6)
kEw3
+ 1 aklF34 j okF23 FijF12i (6.7)
kEw3 jew2
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Given these equations, we predict the effects on all 'j, Xk, and x as 4i is manipulated.
In the intervention experiments, there is little control over how the target is manip-
ulated beyond overexpression (an increase) or silencing (a decrease) for the entire
time course, so we model this simply as unit change 'i = [1111]T. The results of the
changes in all the genes in the network are calculated, and we display the predicted
change in the expression profiles over time in Figures 6-3, 6-4, and 6-5.
In a qualitative way, we select those genes to which the network is most sensitive to
changes. These are the probe sets corresponding to the columns in Figures 6-3 through
6-5 which have the largest effects, either in terms of numbers of genes influenced or
magnitude of change. These are listed in the Table 6.2. While there is some overlap
with the previously identified hubs (identified with asterisks), not all hubs are first
wave genes and not all genes to which the network is sensitive have > 50 outgoing
edges. Three of these genes (FOS, IER2, JUN) were found previously to be expressed
by inducing early response genes with BCR. activation [52], which shows that the genes
that play an important role in the interaction networks also are relevant to the BCR
signaling pathway. The results of the sensitivity analysis, which identify those genes
that peak early in the time course and affect many downstream genes, guide the design
of intervention experiments to test the predictive ability of the networks. We provide
a visualization of a small set of genes for the biologist to evaluate and then to select
for the time-consuming and expensive gene silencing or overexpression. Much like
the testing of binding sites and potential physical interactions related to hub genes,
the selection of targets for intervention is a key step in the process. Though these
results are specific to BCR stimulation and B-CLL, this type of analysis could be used
for other applications in order to systematically analyze the effects of manipulating
regions of a network. In the following subsection, we evaluate the results of one
intervention experiment, the silencing of DUSP1.
6.3.1 DUSP1 Silencing
After BCR stimulation, we identified increased expression of DUSP1 (MKP1), known
to be involved in cell cycle regulation [45] and the inhibition of which potentiates JNK-
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Figure 6-3: For the healthy network, the effects of uniformly perturbing each of the
first wave genes on all other genes in the network over time. The leftmost column
corresponds to the wave label.
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Figure 6-4: For the aggressive network,
the first wave genes on all other genes in
corresponds to the wave label.
m n op q
the effects of uniformly perturbing each of
the network over time. The leftmost column
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dFigure 6-5: For the indolent network, the effects of
first wave genes on all other genes in the network
corresponds to the wave label.
uniformly perturbing each of the
over time. The leftmost column
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Table 6.2: Genes for potential intervention experiments (* hubs)
Column Probe Set
c 220725.x_at
f 209189_at
g 202081_at
j 229563_s_at
e 211998_at
i 201041_s_at
1 205967_at
m 214290_sat
o 224516-sat
a 201041_sat
b 227224_at
d 201044_xat
i 201464_xat
ni 209685_sat
t 226227.xat
H3F3B
DUSP1
HIST1H4C
HIST2H2AA
CXXC5*
DUSP1
R,ALGPS2*
DUSP1
JUN
PRKCB1
TALDO1
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Name
DNAH3*
FOS
IER2
RPL10A*
related apoptosis [53]. We examine the consequences of down-regulation of DUSP1
using small interfering RNA after BCR activation in a patient with the aggressive
subtype of B-CLL in experiments described in detail by Vallat et al. [77]. By silencing
DUSP1, a first wave gene, the effect of the intervention is more local to the peak at
tl than overexpression, which would yield expression that is uniformly high, and the
shape of DUSP1 profile would be lost. Though the shape is not key to the analysis
here where we test the predictive ability of the network, it is important for future
experiments where more control over the expression profile is necessary.
In the Aggressive network, DUSP1 has direct connections to 37 genes. This
subnetwork is shown in Figure 6-6(a). It is important to remember that these do not
necessarily correspond to actual physical interactions, and microarray experiments
cannot provide this information because they only measure mRNA expression levels.
The intervention experiment described in this section, however, will help to identify
which genes are actually influenced as compared to ones that are simply correlated
with DUSPI. In the subnetwork, 25 of the 37 connections are to second wave genes via
F12 (in red), which confirms what was evident globally in the networks in Chapter
5. Most of the interactions are temporally local, despite not having imposed such
a constraint on the inference procedure. One of these connections is to a hub in
the Aggressive network, EGR1, a second wave gene. There are also 136 indirect
connections, many of them through EGRI, which explains in part why DUSPI was
identified as one of the potential target genes to manipulate in the previous sensitivity
analysis. The combination of direct and indirect connections is shown in Figure 6-
6(b).
Experimental Procedure
For the data set used for the DUSP1 experiment, details of the experimental proce-
dure are found in Vallat et al. [77]. While these experiments allow for greater control
over changes in expression, they are difficult to perform. In addition to identifying
the gene targeted for silencing, the RNAi with the correct action must be obtained,
and then it must be delivered inside the primary leukemia cells. It is extremely rare
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(a) Direct connections
4
4
(b) Direct and indirect connections
Figure 6-6: DUSP1 subnetwork (Aggressive network). DUSP1 is white, second wave
genes are red, third wave genes are blue, and fourth wave genes are green.
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to combine silencing, receptor stimulation, and collection of microarray data over
time in a systematic way. Therefore, we have a, unique opportunity to validate the
temporal interaction networks by testing their predictive ability of changes due to
silencing.
In the experiment itself, B cells were isolated from one UM-CLL patient (corre-
sponding to the Aggressive subtype) previously included in the microarray experiment
as described in Section 2.2. Cells were transfected with DUSP1 siRNA or siCON-
TROL non-targeting siRNA. Half of the cells were BCR. stimulated as described
previously, and RNA was collected at the same four time points. After reverse tran-
scription, real time quantitative PCR was performed to assess the silencing effect
observed on DUSPI to confirm that its expression level had been decreased as com-
pared to the control. DUSP1 mRNA expression was analyzed over four time points
and the six experimental conditions (DUSP1 silenced (US/S), siCONTROL non tar-
geting siR.NA transfected (US/S) and control non transfected B cells (US/S)). cRNA
was then hybridized to the HG-HU133 plus2.0 microarray as described previously.
Results
For each gene, we compute differential expression (stimulated minus unstimulated)
for the original patient data, the control, and the silencing. Because of the noisiness
of microarray data, the limitations of the models, and the other patients that were
included in the clustering of the genes and the inference of the predictive models,
we do not expect perfect quantitative predictions. For that reason, we evaluate the
quality of the predictions by whether or not for a given gene, the models correctly
predicted an increase or decrease due to the silencing relative to the control. We
do not predict the value at the first time point because of the temporal causality
constraints, i.e. changes at t1 do riot propagate to the rest of the genes until t2 . This
means that for every gene in the subnetwork, there is a maximum possible score of
three, which corresponds to correct predictions in direction of change at t2, t3, and t4.
Figure 6-7 shows a histograms of these prediction scores on a per gene basis, where
Figure 6-7(a) shows the scores for the 37 genes directly connected to DUSP1 in the
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network and Figure 6-7(b) shows the scores for the 136 indirectly connected genes.
The average prediction scores are 2.05 and 2.15, respectively. Thus for genes that are
expected to be influenced by DUSP1, the model predictions are correct nearly 70%
of the time, considerably better than chance, which would be 50%. Also, in addition
to noise effects, some of the genes would be expected to be simply correlated with,
not influenced by, DUSP1 and would not change predictably.
In Figure 6-7(c), the scores for genes that are linked to DUSP1 neither directly
nor indirectly are shown. These have an average score of 1.21, or correct predictions
approximately 40% of the time. These genes that are unrelated to DUSP1 should, in
theory, have the same expression levels in both the DUSP1 siRNA and the siCON-
TROL trials. Any differences that are seen in the data would be due to noise. The
model is obviously unable to predict these noise effects, so it should do no better
than chance, which is exactly what occurs. This strengthens the results with respect
to those genes that are related to DUSP1, as the model is uniquely able to predict
changes due to gene silencing.
In addition to the aggregate scoring results, we show in Figure 6-8 the actual data,
the predictions, and the input genes for EGR1 (a hub in the Aggressive network).
In the upper left, the differential expression profiles for EGR1 in the original data,
the DUSP1 silencing and the silencing control are shown. We display the network
predictions for each of those three cases in the upper right, and the model predicts
the direction of change correctly at time points t2 and t3. The three smaller plots
consist of the three input genes in the Aggressive network for EGR1, with DUSP1 on
the left. The effect of the silencing on the DUSP1 profile is most evident at tl, where
the differential expression decreases approximately five-fold.
The dominant input to EGR1 is DUSP1, with a connection strength of a =
0.77. While there is no confirmed interaction between EGR1 and DUSP1, these two
genes belong to the same functional group, according to the graph of the MAPK
signaling pathway presented in the KEGG PATHWAY database [40]. DUSP1 is also
known as MKP, and it regulates JUN and FOS transcriptional activity, and thus the
transcription of EGR1. We also show example results for specific genes in Figures 6-9
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Figure 6-7: Histogram of the number of correct predictions per gene (maximum of 3)
for DUSP1 silencing.
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through 6-13, with a mix of successful and unsuccessful predictions and genes from
waves 2, 3, and 4. These are the same style as Figure 6-8, where the actual data is
in the upper left, the prediction in the upper right, and the expression profiles of the
input genes are shown below. For those genes with prediction scores of 3 (Figures 6-9
and 6-10), the connection strengths between the targets and DUSP1 are a = 0.55
and a = 0.49, respectively. Because DUSP1 is the gene with the largest connection
strength for each of the targets, it is reasonable to expect the network to successfully
predict changes. Two genes with lower connection strengths, or less confidence in
the DUSP1-target relationship, are shown in Figures 6-11 and 6-12. Their prediction
scores are zero. Finally, the fourth wave gene shown in Figure 6-13 has a score of
2 and a connection strength of a = 0.4. These results are typical of those from the
remaining 30 genes directly linked to DUSP1.
6.4 Literature comparisons
In the previous two sections, we identified genes that appear to play important roles
in the genetic program of the BCR. signaling pathway by using the structure of the
networks and sensitivity analysis. From previous work in B cells, other genes have
been identified as well. In the following section, we discuss two well-characterized
examples of these, NF-kB and MYC.
6.4.1 NF-kB
The transcription factor NF-kB is believed to play a role in lymphoid tissue devel-
opment, immune, inflammatory, and environmental stress responses, and neuronal
signaling [61, 81]. As the experiments in this work are based on immune response
(activation of the B cell receptor), differences in the signaling response across subject
groups could be related to changes in the NF-kB expression profile or in the genes
that it influences. We investigate NF-kB in the temporal interaction networks and
compare the outgoing edges to known biological interactions.
In the subset of genes selected by the clustering, probe sets corresponding to NF-
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Figure 6-8: EGR1, a network target of DUSP1, prediction score is 2. Top left is the
actual expression profile, top right is the prediction, and the remaining plots are the
input genes.
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Figure 6-9: Network target of DUSP1, prediction score is 3. Top left is the actual
expression profile, top right is the prediction, and the remaining plots are the input
genes.
Prediction error= 0.614248
1500
1000
00
0
1 2 3 4 1 2 3 4
a = 0.49 (336 wl) a = 0.13 (347 w2) a = 0.3 (456 w2) a = 0.061 (461 wl)
4000 4000 4000 4000
200 2000 2000 2000
0 0 0 0
-2000 2000 2000 . 2000
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4
Figure 6-10: Network target of DUSP1, prediction score is 3. Top left is the actual
expression profile, top right is the prediction, and the remaining plots are the input
genes.
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Figure 6-11: Network target of DUSP1, prediction score is zero. Top left is the actual
expression profile, top right is the prediction, and the remaining plots are the input
genes.
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Figure 6-12: Network target of DUSP1, prediction score is zero. Top left is the actual
expression profile, top right is the prediction, and the remaining plots are the input
genes.
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Figure 6-13: Network target of DUSP1, prediction score is 2. Top left is the actual
expression profile, top right is the prediction, and the remaining plots are the input
genes.
kB are present for the Aggressive and Indolent groups. For the Aggressive network,
NF-kB has no outgoing edges. This does not necessarily mean that it does not
influence any other genes, only that it dos not provide the best predictions, either due
to subject inconsistency, noise, or modeling choices, for those genes that it is believed
to target. For the Indolent network, NF-kB has 3 outgoing edges which correspond
to relationships with PIM1, TNIP1, and HLA-F. At least one of these connections,
the edge to HLA-F, has been confirmed biologically as HLA-F is a direct gene target
of NF-kB [61]. TNIP1 [36] and PIM1 [90] are related to NF-kB, but there is not yet
evidence of a direct interaction. Because many of the genes are not annotated and
all interactions are certainly not yet know, verification of local regions of the network
is difficult, but these results show that the inferred links may correspond to physical
interactions in this case.
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6.4.2 MYC
The MYC proto-oncogene is believed to encode a transcription factor and emerged
as one of the top 5% of largest cellular hubs in a transcriptional regulatory network
inferred by Basso et al. [4]. Because MYC is extensively characterized as a transcrip-
tion factor, the inferred interactions were compared to those previously identified
by biochemical methods. In the networks that we inferred in Chapter 5, MYC was
present in all three subject groups (labeled as wave 2 in Healthy and wave 3 for
both Aggressive and Indolent). The expression profiles for each of the subjects are
shown in the top row of Figure 6-14. However, it had no outgoing edges in any of
the networks, which was unexpected. The first possible reason for this was that it is
much larger in magnitude than the cluster means for the waves to which it belongs,
which are shown in the bottom row of Figure 6-14. Because the interaction matrices
(Fk(-,(nput)k(ouput)) are based on the overall mode of interaction between pairs of waves,
the predictions of outlier genes such as MYC are not necessarily well represented.
This modeling choice did not appear to have affected known transcription factors in
the earlier waves but is an issue here.
A second reason for the lack of outgoing edges for MYC is that other genes better
predict the expression profiles of its known targets. We show examples from each
of the three subject groups in Figures 6-15, 6-16, and 6-17. The network inputs for
these genes actually appear to be less consistent than MYC, so either there are inter-
subject differences or noise effects that cause these genes to more accurately predict
the targets.
6.5 Comparisons across subject groups
From Chapter 2, we expect that some genes behave similarly across subjects. Many
of these will be non-BCR pathway related, and there will be no expression difference
in stimulated and unstimulated results. These were intentionally filtered out as part
of the background. Some genes that are be expected to be active in the BCR pathway
may still behave in similar ways across groups, while others will behave differently
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Figure 6-14: The top row has the expression profiles for MYC for each of the subjects,
divided by subject group. The bottom row has the cluster means of the wave class
for MYC.
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Figure 6-15: Prediction and network inputs of an example known target of MYC for
the Healthy group.
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Figure 6-16: Prediction and network inputs of an example known target of MYC for
the Aggressive group.
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Figure 6-17: Prediction and network inputs of a known target of MYC for the Indolent
group.
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Figure 6-18: Overlap of genes selected by wave clustering (500 per group)
either because of genetic differences, which may be related to the disease.
While the clustering is currently done independently within each subject group,
we compare the results across groups. In Figure 6-18, a Venn diagram displays a total
of 1028 genes that are included when all 3 groups are combined. Table 6.3 shows the
consistency of the labeling of the genes in this group. Interestingly, the Aggressive
and Indolent groups are the most similar in terms of the wave labels while in general,
it is the Aggressive group that is most dissimilar from the other two (see Chapter 4).
We can speculate that perhaps the differences between the two B-CLL groups that
cause the drastically differing prognoses is more due to magnitude and not shape of
the relevant gene expression profiles.
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Table 6.3: Wave label comparison across subject groups
Wave 1 Wave 2 Wave 3 Wave 4 Total
Healthy-Indolent 0 31 40 53 124
Healthy-Aggressive 0 20 61 40 121
Aggressive-Indolent 3 31 87 93 211
Healthy-Agg-Ind 0 19 27 28 74
6.5.1 Cross validation
We p)erform leave-one-out cross validation to test the consistency of the clustering
within and across subject groups. As in Section 5.4.4, we use a single subject from
the original data set as the testing data, and the remaining observations as the train-
ing data. We repeat this such that each subject is used once as the testing data,
held out from the clustering of its own type of network (Healthy, Aggressive, or Indo-
lent). For example, for subject Healthyl, the cluster parameters, memberships, and
log-likelihood scores were computed using the data from subjects Healthy2 through
Healthy6. Using the input data for Healthyl, we compute the log-likelihood score for
the data under the cluster parameters estimated from all the aggressive subjects and
the parameters estimated from all the indolent subjects. The results are shown in a
bar plot in Figure 6-19. If we were to use this method to classify subjects into groups
based on the maximum log-likelihood score, only 1 of 6 Healthy subjects are correctly
labeled as Healthy, 4 of 5 Aggressive subjects as Aggressive, and 6 of 6 Indolent sub-
jects as Indolent. The log-likelihood scores corresponding to evaluation under the
cluster parameters for the Healthy and Indolent groups are close to one another in
most cases, which is expected because of the the similarities in cellular behavior for
those two subject groups. Still, this does not separate the subjects successfully. As
we compute the log-likelihood score only based on the 1028 genes (those represented
in Figure 6-18), the classification results are even less successful.
For every subject, evaluation under the Aggressive parameters yields the best log-
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Figure 6-19: Log likelihood scores for leave one out cross-validation, as well as the
scores under the other two sets of cluster parameters
Hel He2 He3 He4 He5 Heb AgI Ag2 Ag3 Ag4 Agb Inl In2 Ind In4 Inb Inb
Subjects
Figure 6-20: Log likelihood scores for leave one out cross-validation, as well as the
scores under the other two sets of cluster parameters, for the 1028 selected genes
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Figure 6-21: Match scores for leave one out cross-validation, as well as the scores for
the other two subject groups.
likelihood scores. The reason for this is, in general, that the Aggressive group has
the largest magnitude differential expression, and the cluster parameters reflect these
large deflections. As we select only the top 500 genes (based on maximum a posteriori
values) from each group, these tend to have larger deflections compared to the re-
maining genes in the same waves, so they fit better under the Aggressive parameters.
Similar to the results in Chapter 3, log-likelihood scores do not necessarily capture
the quality of the clustering. The only thing that it provides here for discrimination
between subject groups is the shape of the expression profiles as opposed to the label
of the gene. For example, a gene may be classified as a second wave gene in the
Healthy group and as long as it fits the second wave cluster parameters for the Ag-
gressive group, the score will be high, even if the same gene is classified as third wave
for the Aggressive group. Therefore, instead of log-likelihood scores, we compute a
"match score," where we count the number of cluster label matches for the left-out
subject and each subject group. For all genes, the results are shown in Figure 6-21.
Under this criterion, 4 of 6 Healthy subjects are classified as Aggressive, and the
other 2 are classified as Indolent. The 5 Aggressive patients are classified correctly. 3
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Figure 6-22: Match scores for leave one out cross-validation, as well as the scores for
the other two subject groups for the 1028 selected genes.
of 6 Indolent patients are classified correctly, as 1 is classified as Healthy, and 2 are
classified as Aggressive. We have already established that there are a considerable
number of genes unrelated to the BCR pathway and likely unrelated to B-CLL that
would be included in the computation. Therefore, we again compute the match score
based only the 1028 genes previously selected (see Figure 6-22).
This correctly classifies 4 of 6 Healthy, 4 of 5 Aggressive, and 6 of 6 Indolent.
One interesting note is that Aggressive5 was actually originally classified in [78] as
a Mutated/Indolent patient, and that is the one that is misclassified here as well.
Regardless, this method correctly classifies 14 of 17 subjects, and while this is not
perfect, it does serve to show that some number of the 1028 genes behave differently
across subject groups.
6.5.2 Network overlap
The network clusters were computed and the predictive models inferred independently
for each subject group, and part of the long term goal of this work is to determine how
to target and treat local differences that occur in a disease-specific sense. A logical
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Table 6.4: Edges in common in the interaction networks
Number of Edges
Healthy-Indolent 9
Healthy-Aggressive 11
Aggressive-Indolent 37
Healthy-Agg-Ind 1
step would be to visualize the networks simultaneously. First, this requires placing
1028 genes and more than 4000 edges in the image, which is shown in Figure 6-23. We
use the colors from the Venn diagram in Figure 6-18 to show which genes are common
across which subject groups. For example, red corresponds to Aggressive only, green
to Indolent only, and yellow to both Aggressive and Indolent. The genes in white are
those that are common to all three subject groups. The wave cluster labels are also
not consistent across subject groups, as was shown in Table 6.3. Therefore, not only
is there a limited subset of genes that are present in more than one subject group, but
those that are may have different labels, so the networks have a very small amount
of overlap with respect to their edges. The number of edges that are in common are
shown in Table 6.4. As before, there is the most overlap between the Aggressive and
Indolent groups, likely because of the greater similarity in wave labels. Because these
common edges comprise only about 1% of the total edges in the combined network
in Figure 6-23, the visualizations that best show the network structure are those that
separate the subject groups completely, as in Figure 5.3.
Ideally, we would infer a combined network by adjusting the formulation described
in Chapter 5 by combining information for all subjects in common parts of the net-
work, those that correspond to general B cell response. It would take advantage of the
additional subject data available for those regions, averaging out non-disease-related
inconsistency and noise. Population or disease-specific differences would then allow
analysis of the relatively small number of genes that discriminate between groups. A
combined network would take us one step closer to determining where exactly the
143
Figure 6-23: Combined network, where the node colors correspond to the colors in
Figure 6-18.
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differences between B-CLL patients and healthy subjects occur, as well as how to
manipulate the cell to repair those differences.
One part of inferring a combined network is determining how to combine subjects
across groups in the assignment of cluster labels. As was discussed in Chapter 4,
given our extremely limited number of subjects, a consistent, meaningful breakdown
of subject groups and genes is not yet possible in our data set. An additional opportu-
nity for future work is in not only combining the subject groups but also in combining
the clustering of the genes with the how they predict their targets. Because of the
simplifying assumptions made in the predictive model inference step, how genes in-
teract is largely determined by which wave class they have been assigned. It is likely
that not all wave 1 genes interact with all wave 2 genes in the same way, for example.
While this could be addressed by allowing predictions to be drawn from a distribution
around the limited modes of interaction, it could also be solved by integrating the
clustering and predictive model inference.
6.6 Summary
In this chapter, we have presented the biological implications of the clustering and the
predictive modeling, providing both confirmatory results and insight into the design
of future experiments. Given the scale-free structure of the temporal interaction
networks, we identified a small number of genes with a large number of outgoing
edges as network hubs. Also, with sensitivity analysis, we propagated the effects
of manipulation of first wave genes to the remaining genes in the network. These
techniques allowed us to select genes that play important roles in the network and
served as starting points for literature comparisons in terms of gene function (e.g.
known transcriptions factors that had been labeled as hubs) and physical interactions.
Guided by previous biological results, we also investigated the behavior of NF-kB and
MYC and their targets. In addition to comparisons to previous work, the results of
anl intervention experiment, the silencing of DUSPI show the predictive ability of the
network. In order to test the network further, and to differentiate between causal
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and correlative relations, similar intervention experiments could be performed based
on the results of the sensitivity analysis.
For the clustering, which has been performed independently within each subject
group, we compared wave labels across subject groups. Leave-one-out cross validation
showed that label match scores based on the subset of genes identified as differentially
active as a result of BCR stimulation are successful in classifying 14 of 17 subjects.
Finally, we combine the genes identified into a single visualization of the interaction
network, address the reasons for presenting the networks separately, and suggest
potential paths for future work.
146
Chapter 7
Conclusions
In this work, we recognized that for B cell chronic lymphocytic leukemia (B-CLL),
understanding the underlying disease process is a vital component in making progress
toward effective diagnosis and targeted treatment. Little is known thus far, except
that the response to B cell receptor stimulation appears to be related to key differences
between the B-CLL patients and healthy subjects, as well as the aggressive and
indolent forms within the B-CLL patient population. We therefore inferred predictive
models of temporal gene interaction for the B cell receptor (BCR) signaling pathway.
To that end, we took advantage of the advances in microarray technology to
collect differential expression data of more than 50,000 genes for 17 subjects (both
healthy and suffering from B-CLL), coarsely sampled with 4 time points over 390
minutes. This large amount of data led us to consider clustering techniques to iden-
tify which genes were most relevant to the BCR signaling pathway and at what times
they were most active. We designed simple statistical models in order to capture
the temporal behavior seen in the pilot study, and estimated the parameters in an
Expectation-Maximization framework, resulting in clusters with a biological interpre-
tation. Compared to a naive approach that did not require any prior knowledge of
the cluster structure, the wave clusters have similar shapes for each patient group,
with smaller intra-cluster variance relative to the means. Both clustering procedures
show that there is statistically significant temporal structure that can be extracted
from the data, but the wave clustering also consistently grouped genes in the same
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waves together and in different waves separately, despite perturbations of the input
data with noise. We have shown for our application that, the wave clustering proce-
dure produces stable, consistent and meaningful models of the differential expression
profiles of genes related to BCR stimulation. In addition, wave clustering serves as a
first step in order to make predictive modeling, as described in Chapter 5, tractable.
Because of the extremely limited number of subjects, the inference problem for
temporal gene interaction is severely ill-posed. Therefore, we used the cluster labels,
which have a consistent biological interpretation, to define a small number of modes
of interaction between the genes. We also imposed sparsity to limit the number of
genes influencing each target gene. Both of these choices were made in order to
make inference tractable, but they are also biologically supported. We tested the
statistical significance of the models, demonstrating that labeling, model constraints,
and connectivity constraints are not arbitrary. We conclude, therefore, that temporal
structure exists and that it can be captured to some degree by a small number of
temporal structures and interaction types.
We showed that the scale-free network structure is consistent with what has been
found in protein interaction networks [8], where a small number of proteins serve
as hubs for very large numbers of interactions. We addressed the issue of distin-
guishing relationships of causality from those simply of correlation with intervention
experiments. Because intervention experiments are expensive and time-consuming to
perform, selection of potential target genes by combining wave cluster labeling and
sensitivity analysis of the networks is an important contribution of this work. The
results of one of these intervention experiments, the silencing of DUSP1 in an pa-
tient with aggressive subtype of B-CLL, showed the models of gene interaction are
uniquely able to predict changes due to gene silencing. This type of biological exper-
iment provides a confirmatory result, but identification of other potential targets of
genetic intervention also guides future experiments.
Though our application here is specific to B-CLL and BCR stimulation, similar
techniques could be applied to virtually any type of experimental conditions because
one of the fundamental problems in biology is understanding genomic function. In
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addition to the purely scientific value, this knowledge can be applied to investigating
the mechanisms of human disease. Predictive models will permit us to investigate the
underlying cause of diseases and help us to develop targeted therapies. While DNA
microarray technology has made it possible to monitor the expression levels for tens
of thousands of genes in parallel, the large number of genes and the complexity of
biological networks greatly increases the challenges of comprehending and interpreting
the data for this purpose. The scale of the experimental data available has increased so
rapidly that it is simply not possible to reconstruct networks manually, and therefore,
interpretation of gene expression data requires sophisticated computational methods
to gain insight into the inner workings of cells. This means that the collaboration in
this work is but one example of how machine learning can provide insights into the
global patterns and relationships of expression in cellular behavior.
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Appendix A
Derivation of the EM Algorithm
In Chapters 3 and 4, we use the Expectation-Maximization algorithm to cluster genes,
subjects, or both. This appendix shows the derivation of the algorithm originally
presented by Dempster, Laird and Rubin [22], with the aid of details in intermediate
steps from a tutorial by Borman [7]. We also provide a simple example of a Gaussian
mixture model and derive the parameter update equations.
A.1 Derivation
The data X is a random vector which results from a parameterized family, and the
goal is to find the values of the parameters e, such that P(XIO) is a maximum, in
the presence of missing or hidden data. The EM algorithm is an efficient iterative
procedure to compute the Maximum Likelihood (ML) estimate by maximizing the
log-likelihood function, which is defined as:
L(8) = In P(XI-) )  (A.1)
At each iteration, we intend to compute an updated estimate of E such that:
L(O) > L(Ok) (A.2)
where the superscript k denotes the value at the current iteration. We therefore
maximize the difference:
L(o) - L(Ek) = ln(P(XIE) - In(P(Xl) k) (A.3)
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We now incorporate the hidden variable, which, in the case of clustering, is the class
label. If the hidden data (labels) were known, we would easily be able to compute
the parameters for each of the classes.
M
P(XIO) = P(Xm', e)P(mlO) (A.4)
m=~
Substituting back in to Equation A.3:
M
L(O) - L(8k) = In E P(Xlm, O)P(ml8) - In P(XIEk) (A.5)
m=1
At this point, we introduce Jensen's Inequality, which states:
N N
In E Anxn An In xn (A.6)
n=1 n=1
where:
An 0 (A.7)
N
SAn = 1 (A.8)
n=1
In this case, P(mIX, Ok), the posterior probability of a given class, fulfills both of
these conditions for An. We substitute back into A.3 again, this time using Jensen's
Inequality to move the summation outside the log:
L(-)) - L(ok) = In E P(XIm, E)P(m E) - In P(X)( k) (A.9)
m=1 P(mJX, Ek)
M1
Our objective is to choose values of O so that L(8) is maximized, so we define the
function Q(08|k) that is guaranteed to be less than or equal to L(O):
Q(H Gk) = L(ek) + i P(m X, Ok)n P(Xjm, e)P(m e) (A.11)
m=1
In the Expectation Step, we compute P(mIX, ek) based on the current parameter val-
ues, and then in the Maximization Step, we use that compute Ek+1 which maximizes
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Q(elok):
Ek+l = arg max Q(El k) (A.12)
e
M P(Xim, H)P(mjE)
= arg max L(Ek) + E P(mlX, e k) n P(Xm,e)P(mlk)) (A.13)
e m=lP(mlX,k)P(X k)
M
- arg max P(mlX, Ok) In (P(Xlm, O)P(mle)) (A.14)
m=1
A.2 EM Example
We provide a very simple example of how the EM algorithm can be used for clustering.
The EM equations are derived for the case of a mixture of Gaussians, in which the
class label is the hidden data. The derivations are similar for the more complicated
clustering in Chapters 3 and 4.
A.2.1 Generative Model
The data X is an Nxl vector, which we assume has been generated from a mixture
of M Gaussians, each with a mean /p and variance u 2. Ok includes all parameters of
all the clusters at iteration k.
M N
P( (9) = E J P(x,, , (9) (A.15)
m=1 n=1
A.2.2 Expectation Step
PP(xnm, (k)k)P(mjOk) (A.16)
P(ml , k) = M Ok(A.16)k)
EM,=1 P(xnM, k)P( k)
= Wnm (A.17)
This provides an NxM matrix of weights that will be used to compute the parameters
in the Maximization Step. Specifically for the mixture of Gaussians:
P(x,Im, k)= 1 exp 2 (A.18)
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where P(m ()k) is the current mixture proportion for class m under the parameters
8k.
A.2.3 Maximization Step
We first assume a product model, in which each element of F is an independent draw:
P(£lm, ) = (A.19)
N
H P(x m', O)
n=l
and by taking the log of both sides:
N
In P(Alm, E) = In P(xzlm, ))
n=1
(A.20)
(A.21)= In P(x,lm, 6)
n=1
The expectation over all possible models is then:
(A.22)
(A.23)
m=1
M N
= E Wnm
m=1 n=1
Therefore, the computation of Q((-)Ok) reduces to:
M NQ(k 0k) = L()k) + Z
m=1 n=1
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(A.24)
M N
ZE 1 P((j.n, Ok)
m=l n=l
P(mlI, ek) k
wnm In(P(xn lm, 8)P(m ))
We begin with /t for a given class m and drop all the terms that do not depend on M
as we simplify:
N
arg max E wnl I(P(x Im, e)P(mle)) (A.25)
n=1
N
arg max E wnm(ln P(xnIm, 8) + In P(m 8)) (A.26)
n=1
N
arg max E wnm(ln P(xnlm, 0)) (A.27)
n=1N
N 1 
-(x - _t)2 (A.28)
arg max E Wnm(n exp 2 8)
E n=1 r22or
arg max Wnm- I2  2  (A.29)g n n=1 2'2
(A.30)
Taking the derivative with respect to [L and setting it equal to zero gives us:
N
SWnm(Xn - ) = 0 (A.31)
n=1
Solving for up:
N-n=1 WnmXn (A.32)
n=1 Wnm
This is equivalent to taking a weighted average of the data to compute the cluster
mean. In a similar way, the variance for a cluster is (using the value for /t just
computed):
a2 _ E 1 Wnm(n 
- )2 (A.33)
En=l Wnm
Finally, the mixture proportions require the addition of an additional constraint be-
cause they must sum to one:
N M
arg max w,, In(P(xn m, 8)P(mO)) - A( P(mle) - 1) (A.34)
n=l m=1
N M
arg maxE wnm(ln P(xn m, ) - In P(mle)) - A( P(mlI)) - 1) (A.35)
n=1 m=1
N M
arg max wnm(lnP(m|E)) - A( P(ml) - 1) (A.36)
G n=1 m=1
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Taking the derivative with respect to P(m|O) and setting it equal to zero gives us:
En=Wnm -A = 0 (A.37)
P(mle)
Rearranging to solve for P(mlO) yields:
N
P(nml) = E Wnm (A.38)
n=1
To solve for A, we sum both sides over M:
M MNSP(ml-e)= Wnm (A.39)
m=1 m=1 n=1
By definition, the left side is equal to 1, so:
MN
A : EWnm (A.40)
m=1 n=1
NM
E EWnm (A.41)
n=1 m=1
N
= 1 (A.42)
n=1
=N (A.43)
Finally, substituting in the value for A:
P(mle) = - Wnm (A.44)
n=1
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